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Abbrevations 
AT  Applied tension 
AUC  Area under the curve 
BAT  Behavioural avoidance test 
BII phobia Blood-injury-injection phobia 
BIP  Blood-injury phobia 
CBT  Cognitive Behavioural Therapy 
CFSS-DS Children's Fear Survey Schedule-Dental Subscale 
DSM-5 Diagnostic and Statistical Manual of Mental Disorders 5th edition 
E-OIP  Extra-oral injection phobia 
IOIF-s Intra-Oral Injection Fear scale 
I-OIP  Intra-oral injection phobia 
IP  Injection phobia 
IS-c  Injection Phobia Scale for children 
ITG  Immediate Treatment Group 
ITT  Intention-to-treat 
MQ-c  Mutilation Questionnaire for children 
PDS   Public Dental Service    
RCT  Randomized Controlled Trial 
ROC  Receiver Operating Characteristics 
WCG  Waitlist-Control Group 
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Abstract 
Background: Intra-oral injections are common procedures within dentistry, 
performed in order to avoid procedural pain. Nevertheless, little is known about the 
prevalence of high intra-oral injection fear, or treatment of intra-oral injection phobia 
among children and adolescents. Aims: The overall aims were to gain more 
knowledge about the prevalence of high intra-oral injection fear among children and 
adolescents, to validate the novel Intra-Oral Injection Fear scale (IOIF-s), to clarify 
the overlap between intra-oral injection fear and dental fear, and to explore the 
possible effectiveness of cognitive behavior therapy (CBT) among children and 
adolescents with formally diagnosed intra-oral injection phobia (I-OIP). Methods: 
The study comprised two parts, both carried out in Hordaland County, Norway. Study 
I was a cross-sectional study among 1460 10- to 16-year old pupils. Data were 
collected by use of questionnaires, including the novel IOIF-s. Study II was a 
randomized and controlled treatment study in 67 patients within the same age group, 
fulfilling the DSM-5 criteria for I-OIP. The patients were randomly assigned to either 
an immediate treatment group receiving CBT, or a waitlist-control group. The 
treatment was performed by dentists specially trained in CBT. Subjective and 
behavioural measures of effectiveness of the treatment were assessed. Results: 
Crohnbach’s alpha of the IOIF-s was 0.95. Further the IOIF-s was found to 
discriminate between participants with and without I-OIP. In total 13.9% of the 
children reported high fear of intra-oral injections based on the IOIF-s. A strong 
association between fear of intra-oral injections and dental fear was revealed. CBT 
had significant effect compared to no treatment both measured subjectively by self-
report scales, and behaviourally by receiving intra-oral injections. Conclusions: The 
IOIF-s has satisfying psychometric properties in terms of reliability and validity. 
Further, high intra-oral injection fear was found to be prevalent among the targeted 
age group, and is associated with avoidance of necessary dental treatment. CBT 
performed by specially trained dentists is an efficient treatment among children and 
adolescents diagnosed with intra-oral injections. 
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Intra-oral injection phobia is a subgroup of the blood-injury-injection phobia, one of 
the five specific phobias classified in the Diagnostic and Statistical Manual of Mental 
Disorders-5 (DSM-5) (1). Within dentistry, intra-oral injections are common 
procedures, performed in order to avoid procedural pain. Pain and anticipation of 
painful dental experiences are found to be predictors for the development of dental 
fear (2). Sufficient pain control in relation to dental treatment in children is therefore 
of vital importance. Intra-oral injections are found to be among the most fear-
provoking stimuli for children in a dental setting (3, 4). Nevertheless, little is known 
about the prevalence of high intra-oral injection fear among children and adolescents. 
This may partly be due to the absence of psychometric measurement tools assessing 
the intra-oral injection fear. Furthermore, in the young population little is known 
about the consequences of high fear of intra-oral injections, or the association 
between intra-oral injection fear and dental fear. Even though blood-injury-injection 
phobia may have its onset in childhood (5-7), there is a lack of evidence based 
interventions for children and adolescents suffering from intra-oral injection phobia. 
 This thesis concerns assessment, prevalence and treatment of intra-oral 
injection phobia in children and adolescents. Psychometric properties and 
applicability of a novel self-report scale assessing intra-oral injection fear will be 
evaluated. The prevalence of high intra-oral injection fear is examined, as well as the 
overlap between high intra-oral injection fear and high dental fear. Furthermore, the 
consequences of high fear of intra-oral injections in terms of avoidance of dental 
treatment requiring intra-oral injections will be discussed. Finally, the effectiveness 
of 5-sessions of cognitive behaviour therapy (CBT) performed by specially trained 
dentists, is explored in a sample of children and adolescents with formally diagnosed 




1.1 Fear, anxiety and phobia, definitions 
Fear, anxiety and phobia are related emotions and are often used interchangeably in 
literature. The function of the rather similar emotional experiences fear and anxiety 
is to generate adequate adaptive responses when exposed to threats, danger and 
motivational conflicts (8). The feared object is suggested to be characterized as 
"real", "objective" and "known", whereas the anxiety provoking object is described as 
"unclear or uncertain" (9). The core point of anxiety has been described as a sense of 
uncontrollability (10). Depending on the context, the responses of fear and anxiety 
are usually mild, short-term and reasonable (11). By activation of the autonomic 
nervous system, the fear/anxiety response exhibits four types of symptoms that 
facilitate the "fight-or flight" response, enabling either immediate escape or attack of 
feared stimuli (12). The physiological or somatic symptoms, as a consequence of 
arousal of the sympathetic nervous system, include adrenaline secretion, increased 
perspiration, increased heart rate and muscle tension. Emotional symptoms are 
displayed essentially in terms of fearfulness and apprehension. Furthermore, 
cognitive symptoms include anticipation of harm, fear of losing control and finally 
behavioural symptoms such as avoidance or escape from feared situations (11, 13). 
To summarize, the terms fear and anxiety display the same physiological responses. 
However, as described by Barlow, fear is a reaction to a present triggering stimuli or 
the danger imminent, whereas anxiety is future-oriented and corresponds to a threat 
that has not yet occurred (9). 
 In anxiety disorders, the frequency and intensity of fear/anxiety responses are 
out of proportion to the situations that trigger them and the responses interfere with 
daily life. Although these distinctions are often not very sharp, delineations can be 
made between an adaptive response to a threat, which can be termed adaptive fear 
and a maladaptive anxiety response (11). In adaptive fear, individual cognitions and 
concerns are realistic given the circumstances, the amount of fear experienced is in 
proportion to the reality of the threat and the fear response subsides when the threat 
ends. In maladaptive anxiety, on the other hand, individual concerns are unrealistic, 
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the fear experienced is out of proportion and the concern persists when the threat 
ends.  
 Anxiety disorders take a number of different forms, including phobic 
disorders. Phobias are exaggerated and irrational fears of certain objects or situations 
(1). Hence, when the fear/anxiety response reaches extreme levels, and significant 
distress and impairment of functioning is reported, the state may be defined as a 
phobia, classified in the Diagnostic and Statistical Manual of Mental Disorders -5 
(DSM-5) as an anxiety disorder (1). Individuals with phobias recognize their fear as 
irrational, yet their solution is often to make attempts to avoid the feared situation or 
object.      
 Phobia is a clinical diagnosis that can only be diagnosed by trained 
professionals such as psychologists or physicians. A thorough evaluation should 
include a structured or a semi-structured interview, self-report measures and 
behavioural assessments (14). In epidemiologic studies, self-report instruments with 
cut-off scores are often utilized to separate a subclinical from a clinical fear level, or 
to separate low-, mild- and high fear levels (15). Differences in measurement 
methods, study designs, study samples, the informant assessed (e.g., child, parent, 
observer), cut-off scores and the terms used may cause inconsistent prevalence 
figures (15, 16). In the data obtained and collected for the present thesis, the term 
“fear” is used to assess fear and anxiety levels, whereas the term “phobia” is used 
only when an individual is diagnosed by a clinical psychologist. 
 
1.2 Specific phobia 
The anxiety disorder, specific phobia, is defined as a "marked and persistent fear that 
is excessive or unreasonable, cued by the presence of anticipation of a specific object 
or situation.” (1). Specific phobias fall into one of five categories: 1) animal type, 2) 
natural environment type, 3) situational type, 4) blood-injection-injury type and 5) 
others. Although the different specific phobias possess similar dimensions, they differ 
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in several aspects including age of onset, focus on apprehension, sex composition, 
timing of the phobic response and type of physiological reaction during exposure 
(17). The following criteria are needed to meet the diagnostic criteria for a specific 
phobia diagnosis according to the DSM-5 (300.29) (1):  
A. Marked fear or anxiety about a specific object or situation (e.g., flying, heights, 
animals, receiving an injection, or seeing blood). Note: In children, the fear or 
anxiety may be expressed by crying, tantrums, freezing, or clinging. 
B. The phobic object or situation almost always provokes immediate fear or anxiety.  
C. The phobic object or situation is actively avoided or endured with intense fear or 
anxiety. 
D. The fear or anxiety is out of proportion to the actual danger posed by the specific 
object or situation and to the sociocultural context. 
E. The fear, anxiety or avoidance is persistent, typically lasting for 6 months or more.  
F. The fear, anxiety, or avoidance causes clinically significant distress or impairment 
in social, occupational, or other important areas of functioning.  
G. The disturbance is not better explained by the symptoms of another mental 
disorder, including fear, anxiety, and avoidance of situations associated with panic-
like symptoms or other incapacitating symptoms (as in agoraphobia); objects or 
situations related to obsessions (as in obsessive-compulsive disorder); reminders of 
traumatic events (as in posttraumatic stress disorder); separation from home or 
attachment figures (as in separation anxiety disorder); or social situations (as in 
social anxiety disorder). 
 
Excessive fears of specific objects or situations are common in young children. 
However, often the phobia diagnosis is not applicable as the degree of impairment is 
only mild and transitory and thus considered developmentally appropriate (1, 18). As 
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these fears in children may be transient, the DSM-5 describes the duration of 
symptoms of typically 6 months or more to diagnose a child with specific phobia. 
Furthermore, children in contrast to adults are less capable of recognizing their fear as 
irrational and excessive. Young children typically are not able to understand the 
concept of avoidance. Accordingly, additional information should be sought from 
significant others. Crying, freezing, tantrums or clinging may express fear and 
anxiety in a young child. The prevalence rates of specific phobias are approximately 
5% in younger children and approximately 16% in 13- to 17-year-olds (14).   
 
1.2.1 Blood-injury-injection phobia 
Individuals with blood-injury-injection (BII) phobia are characterized by extreme and 
excessive fear and avoidance cued by seeing blood or injuries or by seeing or 
receiving injections or other invasive medical procedures. It has been suggested that 
individuals with BII types phobias may be especially internally focused on their fear 
and seem concerned about sensations indicating impending faintness (14). BII phobia 
can be divided in two main subgroups: blood-injury phobia (BIP) and injection 
phobia (IP) (19). It has been shown that IP can further be divided into separate, 
sometimes overlapping conditions, namely extra-oral IP (E-OIP) and intra-oral IP (I-
OIP) (20).  
 BII phobia has a complex and multifactorial aetiology. Factors involved in the 
development and maintenance of the phobia include negative learning experiences, 
aberrant brain processes, temperament (behavioural inhibition), learning experiences, 
evolutionary preparedness, avoidance and cognitive biases (20-22).  
 The tendency for individuals with BII phobia to be associated with fainting in 
the phobic situation is one of the most distinct features compared to other specific 
phobias (6, 19). However, it has been debated whether this feature is representative of 
the whole population of individuals with BII phobia (23, 24). A diphasic 
physiological response is mediated by the sympathetic nervous system, manifested by 
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an initial increase in heart rate and blood pressure. This typical physiological fear 
response is followed by a sharp drop in heart rate and blood pressure due to activation 
of the parasympathetic nervous system,  possibly leading to fainting (19, 23, 25). 
From an evolutionary perspective, the drop in blood pressure and fainting may 
represent an adaptive response to injury and excessive blood loss (14). The frequency 
estimates of fainting associated with BII stimuli are inconsistent. Öst found that 
approximately 70% of individuals with blood phobia experienced this response at 
times, whereas the corresponding proportion in individuals with IP was 56% (19). 
However, a study among 60 BII phobia participants reported that only 20% showed 
diphasic responses when exposed to surgery (23).Vika et al. reported that among 18-
year-olds, 15.9% nearly fainted, whereas 1.7% fainted in relation to dental injections 
(26). In contrast to other phobias, individuals with BII phobia in some studies have 
reported a strong family history with a biologically predisposed autonomic response 
leading to a tendency to faint (27, 28). A significant familial aggregation of blood 
fear has been reported, indicating a possible genetic inheritance (19, 28, 29). A 
possible mediator for fainting associated with BII stimuli, especially for the blood 
phobia subtype, is disgust (30). The basic emotion of disgust is reported in relation to 
the trigger in individuals with BII phobia and is characterized by activation of the 
parasympathetic nervous system, manifesting in nausea, dizziness and fainting (31).     
  The onset of BII phobia is usually prior to 10 years of age (5-7) and the 
lifetime prevalence is reported to vary approximately 3.0%-4.5% (6, 7, 17, 32). A 
study by Oosterink et al. found the prevalence of subgroups of BII phobia to be as 
follows: blood phobia 1.0%, injury phobia 0.8% and injection phobia 1.1% (33). In 
some studies, females are found to report BII phobia more often than males (6, 34), 
but the sex differences are more inconsistent, and not as prominent, as in other 
specific phobias (1, 33, 35). There is a lack of knowledge of equivalent prevalence 




1.2.1.1 Intra-oral injection phobia 
Characteristic for the subtype I-OIP is the extreme and excessive fear of intra-oral 
injections or situations or stimuli associated with intra-oral injections (20). Triggers 
may include seeing the syringe/needle, the feeling of being anaesthetized, sensations 
of swelling gums, fear of allergic reactions and seeing a picture of a syringe. Intra-
oral injections are mainly used for local anaesthesia during dental treatment to 
prevent procedural pain. Hence, avoidance of intra-oral injections due to fear may 
cause individuals to undergo painful dental procedures or avoid dental treatment that 
requires local anaesthesia. Negative or painful dental experiences or anticipated fear 
of them are found to be predictors for developing dental fear and anxiety (2, 36, 37).   
 Studies have found intra-oral injections to be among the most fear-provoking 
stimuli related to the dental setting (3, 38, 39). Dutch children reported that the 
prevalence of fear of needles related to dental treatment decreased with increasing 
age (40). Among 10- to 11-year-olds, the prevalence was 11% compared to 19% 
among 4-6-year-olds. However, this study is based on the response to a single item 
and does not cover different aspects of the fear response. In a large sample of 18-
year-olds, during their last intra-oral injection 17% experienced a high level of fear 
(26). Of those reporting high fear of injections during their last dental or medical 
injection, 8.1% were highly fearful of both intra- and extra-oral injections, and the 
prevalence was higher among girls than boys. Additionally, if they knew that an 
intra-oral injection was required 3.3% reported avoidance of dental treatment. 
Correspondingly, 4.6% of students and staff at the University of Washington avoided 
intra-oral injections due to fear (41).   
 The hitherto lack of an adequate assessment tool for intra-oral injection fear 
may be one of the reasons for the inconsistent and absent prevalence of figures in 
children and adolescents. A scale assessing injection fear, referred to as the Injection 
Phobia Scale for children (IS-c), is an 18-item rating scale designed for self-reporting 
of injection fear in children and adolescents (42). However, only one item covers 
intra-oral injection fear, and the remaining items mainly cover situations related to 
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extra-oral injections such as blood samples and vaccines. Similarly, the widely used 
Children’s Fear Survey Schedule - Dental Subscale (CFSS-DS), a scale used for 
measuring dental fear in children has only one item covering fear of intra-oral 
injections (43). This lack of a proper assessment tool led a research group at the 
University of Bergen, Norway to develop the Intra-Oral Injection Fear scale (IOIF-s) 
for children and adolescents. The research group drafting the novel IOIF-s included 
Professor Lars Göran Öst (psychologist), Professor Magne Raadal (dentist), Professor 
Erik Skaret (dentist) and Margrethe Vika (psychologist, PhD).   
  The early onset of BII phobia, in addition to the associated negative 
consequences of I-OIP, illustrates the need for early and correct identification. 
 
1.2.1.2 Dental phobia 
Dental phobia refers to extreme or excessive fear of dental treatment procedures or 
associated stimuli, leading to avoidance of necessary dental treatment or endurance of 
dental procedures with intense fear. Pain related to the dental situation, especially in 
combination with a sense of lack of control, is shown to considerably increase the 
risk of a high level of dental fear (2, 36, 44). Common negative cognitions include 
pain experienced as intolerable, loss of control, being subject to negative behaviour 
from the dentist, feeling ashamed in the treatment situation, invasive procedures and 
sights and sounds of stimuli (3, 45, 46). Avoidance of dental treatment due to fear 
may cause more extensive treatment problems including pain, which in turn may lead 
to maintenance or aggravation of the fear (47).  
 The prevalence estimates of a high level of dental fear in children vary greatly, 
partly due to differences regarding age groups studied, informants assessed (child vs 
proxy), study designs, measuring tools, cut-off scores, geography, culture and terms 
utilized. This often makes prevalence comparisons challenging or impossible. 
However, the prevalence of high dental fear has been reported to be between 3.3% 
and 20.6%, with girls often, but not always, displaying proportionally more 
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fearfulness than boys (2, 48-50). Although the results are inconsistent (48), some 
studies have revealed decreasing dental fear with increasing age (4, 51). However, the 
associations are not always very strong. 
 
1.3 Overlap between subtypes of BII phobias and dental phobia 
Dental treatment includes invasive medical procedures, and dental phobia is 
categorized in the DSM-5 as part of BII phobia (1). This classification is debated 
however, as research is inconsistent (17), and accumulating evidence suggests that 
dental phobia should be considered a specific phobia independent of the BII phobia 
subtype (38, 52-54). In the World Health Organization diagnostic manual, known as 
the International Classification of Disorders (ICD-10), dental phobia is categorized as 
a specific phobia (F40.2) (55). Further sub classification of the specific phobia 
category similar to the DSM-5 does not occur.    
 Le Beau et al. concluded that dental phobia and BII phobia shared more 
similarities than differences (17). A Dutch study, however, assessing the relationship 
between dental phobia and either BII phobia or avoidance of BII related stimuli 
among dental patients, concluded that there were only weak nonsignificant 
correlations between these constructs (38). However, 57% of the patients with dental 
phobia could also be classified as individuals with BII phobia. Hence, the relationship 
between BII phobia subtypes and dental phobia is still unclarified. By looking at BII 
phobia and dental phobia as separate conditions, substantial but varying estimates of 
overlap have been documented. 
 The overlap between dental fear and BII fears seems more often to be reported 
with a larger proportion of the dentally fearful individuals being fearful of injections 
than fearful of blood. In a study by Öst it was found that 18.6% and 8.6% of those 
characterized with IP and blood phobia, respectively, also had a high level of dental 
fear (19). However, in this relatively small proportion of individuals with blood- and 
injection phobias with dental fear, the fear was found to be mediated by fear of 
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injections during dental treatment. In a similar study, but in non-diagnosed adults, it 
was concluded that although blood-injury fear was found to be a significant 
component of dental fear, the overall contribution was small (56). Poulton et al. 
revealed that among dentally fearful individuals (not diagnosed by psychologists), 
10% reported a comorbid fear of blood, whereas 53% reported a comorbid fear of 
injections (57).  Further it was indicated that dentally fearful individuals who were 
also fearful of injections were at especially high risk of adverse oral health outcomes. 
These findings are further supported by de Jongh et al., who reported that high 
proportions of individuals with dental phobia feared dental procedures such as 
"receiving anaesthetic injections" (39.0%), whereas only a small proportion feared 
the sight of blood (7.3%) (38).   
 In a sample of Norwegian 18-year-olds, dentally fearful individuals scored 
significantly higher on the scales assessing blood-injury and injection fear compared 
to individuals who were not dentally fearful (58). The authors stated that this 
indicated a relationship between BII phobia and dental phobia and suggested that BII 
phobia may be a background factor causing some individuals to become dentally 
anxious when exposed to dental injections. This relationship needs to be further 
explored, as research in this area is lacking in children.     
 
1.4 Treatment 
Cognitive behaviour therapy (CBT) is considered an evidence-based and effective 
treatment for specific phobia in children and adolescents (59-61). Usually, CBT for a 
specific phobia is brief and time-limited and involves 8-11 weekly sessions (62). 
Nevertheless, Öst has shown that specific phobias can be treated in a single 3-hour 
treatment session, referred to as "one session treatment (OST)" (63). OST is now also 
considered a well-established treatment for children and adolescents (64). The 
treatment involves exposure-based therapy including hierarchical presentation of the 
feared stimulus, psychoeducation, participant modelling and targeting catastrophe 
cognitions by the child (63).  
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 However, children and adolescents with BII phobia are highly 
underrepresented or excluded in many treatment studies of specific phobia. The 
exclusion has partly been explained by poor treatment response and a more complex 
clinical presentation, making children with BII phobia more difficult to engage in 
exposure therapy (59, 60). Öst et al. included 60 adolescents with specific phobias, 12 
with IP and 2 with blood phobia (61). The adolescents with BII phobia revealed a 
significantly less favourable treatment response. Another controlled trial involving 43 
7- to 17-year-olds diagnosed with specific phobia, of which 6 had BII phobia, found 
exposure treatment to be superior compared to a waitlist control (65). However, in 
this study the treatment outcomes for the different specific phobias were not 
examined separately. 
 A modified and individualized OST approach for BII phobia in children has 
been described in a study by Oar et al. (22). The modifications performed to enhance 
treatment outcomes for BII phobia in children and adolescence included addressing 
the roles of pain, disgust and fainting. Furthermore, the efficacy of this modified OST 
in a sample of 24 8- to 18-year-olds with BII phobia was also examined in a 
controlled trial (66). After treatment, 33.3% of the participants did not meet the 
criteria for a diagnosis, whereas following a 4-week electronic based therapy 
maintenance program, 62.5% did not meet the diagnostic criteria at 3-month follow-
up. However, none of the individuals with BII phobia were explicitly diagnosed with 
the subtype I-OIP.  
 To the best of our knowledge, there are no randomized controlled studies 
exploring the effect of CBT among children and adolescents diagnosed with I-OIP. A 
literature search in PubMed revealed that few studies have focused on intra-oral 
injections at all (Table 1). However, 89% of adults with I-OIP were successfully 
treated by CBT in a randomized controlled study by Vika et al. (67). This study 
employed collaboration between clinical psychologists and dentists specially trained 
in CBT for I-OIP and dental phobia. Because of the lack of knowledge of treatment 
of I-OIP in children and the early onset of BII phobia in general, combined with the 






Author Country  
 
Year  Age group Focus of interest Objectives 








A description of needle 
desensitization for paediatric 
patients. 
Kuscu OO & Akyuz S Turkey 2008 9–13 years Electronic 
computerized 
devise. 
To investigate the 
influence of anxiety and type of 
dental injection, 
a plastic syringe or an electronic 
computerized 
device, on the pain perceived by 
children. 
 




2004 4 - 11 years  Needle phobia. 
Dental anxiety. 
To explain the nature of needle 
phobia and its relationship in 
dental phobic children with 
evidence on age-related 
differences. 
 
Al-Namankany A et 
al. 
USA 2014 6-12 years Video modelling.  
Dental injection 
anxiety. 
To  investigate if video 
modelling can influence a child's 
anxiety before administration of 
dental injections 
Nieuwenhuizen J et al. The 
Netherlands 
2012 4-6 years Comuter-controlled 
local analgesic 
delivery system.  
Dental anxiety. 
To compare two different 
computer-controlled local 
analgesic delivery systems in 
terms of pain and stress reaction. 
Krekmanova L et al. Sweden 2009 8-19 years Dental anxiety. 
Painful dental 
injections. 
To study everyday- and dental 
pain experiences in relation to 
gender, age and dental anxiety. 
Versloot J et al. The 
Netherlands 
2008 4-11 years Dental anxiety. 
Children's behaviour 
before and during 
local anaesthesia 
injection. 
To examine the levels of dental 
anxiety and earlier experience 
with dental injections and the 
possible influence on children's 
behaviour before and during a 
local anaesthesia injection. 
 
Bågesund M & 
Tabrizi P 




To evaluate the effectiveness of 
intraoral topical anaesthetics  
Weinstein P et al. USA 2003 7-9 years Videotaped 
intervention. 
Anxiety of the pain 
of dental injections.  
To assess a videotape used to 
enhance child perceived control 
in a dental setting. 
Rosenberg ES USA 2002 13-80 years Computer-controlled 
anesthetic delivery. 
To evaluate level of anxiety an 
pain associated with computer-
driven anaesthetic delivery 
Table 1. The table displays the results from an electronic literature search from PubMed, performed 15th Aug, 2016. 
Inclusion criteria were reviewed published articles, written in English from Aug 15th 1986 to Aug 15th 2016. The search 
algorithm was (intra oral injection fear OR intra oral injection anxiety OR intra oral injection phobia OR dental injection 
fear OR dental injection anxiety OR dental injection phobia OR needle injection fear OR needle injection anxiety OR 
needle injection phobia) AND (child OR children). The number of Titles/Abstracts originally identified was 3. After 
excluding articles not covering children and adolescents up to the age of 16, and not considering specific intra-oral 




The overall aims of the thesis were to gain more knowledge about the prevalence of 
high fear of intra-oral injections among children and adolescents, the overlap between 
intra-oral injection fear and dental fear, and to explore the possible effectiveness of 
CBT among children and adolescents with formally diagnosed I-OIP when performed 
by specially trained dentists.  
More specific aims were: 
 In a general population of 10- to 16-year-olds: 
 Evaluate the usefulness (reliability and validity) of a new self-report 
scale assessing fears of intra-oral injections. 
 Assess the prevalence of self-perceived high fear of receiving intra-oral 
injections. 
 Estimate the prevalence of high BII fear subtypes.  
 Explore the overlap between fear of intra-oral injections and dental fear. 
 Evaluate the possible consequences of fear of intra-oral injections in 
terms of avoidance of dental care. 
In a sample of children and adolescents with formally diagnosed I-OIP (DSM-
5): 
 Evaluate the effectiveness of cognitive behaviour therapy (CBT) when 







2.0 MATERIALS AND METHODS 
This thesis is based on two different studies conducted in Hordaland County, 
Norway. Study I was a cross-sectional questionnaire study (population study). Study 
II was a randomized controlled treatment study with a 1-year follow-up design. Paper 
1 is based on data from both Study I and Study II. Paper 2 is based on Study I, and 
Paper 3 is based on Study II. 
 
2.1 Sample size calculation and sample selection   
2.1.1 Study I 
A pilot study reporting a 6% prevalence of high fear of intra-oral injection formed the 
basis for the sample size calculation. Additionally, an absolute precision of 2% with a 
95% confidence interval yielded a sample size of 550 pupils. A sample size of 1100 
was needed to detect differences in prevalence between the two age groups (10- to 
12-year-old pupils vs 13- to 16-year-old pupils) and between sexes. The final sample 
size was set to 1400, assuming an anticipated drop-out rate. The total population of 
10- to 16-year-old pupils in Hordaland County at the time of the study was 
approximately 44000 according to Statistics Norway (68).  
  As classical conditioning is found to be one of the main aetiological factors in 
BII phobia (69, 70), sampling was performed on the basis of public dental clinics to 
minimize the effect of single dentists treating all pupils in the area. The pubic dental 
clinics in Hordaland County were arranged and listed from largest to smallest. 
According to the list, public elementary schools belonging to the catchment areas of 
the largest public dental clinics were first invited to the study. The schools in the 
catchment areas of the subsequent public dental clinics of the list were then invited. 
When the required sample size was reached, the selection of schools stopped.  
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2.1.2 Study II 
Because empirical data to support a power analysis was lacking, the following power 
analysis calculation was performed: An active treatment group (Group I) was 
compared to a waitlist-control group (Group II), which was put on a waitlist for 5 
weeks before being enrolled for treatment (Paper 3, Figure 1). An estimated effect 
size (Cohen's d) of least 0.80 was utilized. Furthermore, a significance level of 0.05 
and a power of 80% led to a required group size of 26 patients (71). Previous findings 
in CBT studies of specific phobias in children reported an estimated attrition rate of 
approximately 10% (72), yielding a total sample size of at least 60 patients. 
Consequently, a final sample size was set to 68, yielding 34 patients in the immediate 
treatment group (ITG, Group I) and 34 patients in the waitlist-control group (WCG, 
Group II). 
 All patients were enrolled consecutively from the group of patients referred for 
treatment to the Centre for Odontophobia within the study enrolment interval (Aug. 
2013- June 2015). These patients were referred from the Public Dental Service 
(PDS), as they were not able to receive intra-oral injections. The inclusion criteria 
were: a) 10- to 16-years-old; b) a primary diagnosis of  I-OIP according to the DSM-
5 criteria (1); c) acceptance of comorbidities with other phobias as either secondary 
diagnoses or co-primary diagnoses with I-OIP; d) willingness to try exposure 
treatment; and e) willingness to participate in the study for a period of 1 year. 
Exclusion criteria included disorders including primary depression, drug or alcohol 
abuse, cognitive developmental disorder or psychotic symptoms. 
 
2.2 Study design and procedure 
2.2.1 Study I 
Data collection for this cross-sectional questionnaire study was conducted between 
Jan. 2014 and March 2015 and was completed by the pupils in their respective 
classrooms (45 min) while supervised by the first author. Prior to the study, an 
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information sheet for the parents/guardians was distributed by the teacher to the 
pupils and was also sent to the parents/guardians by e-mail. Optional participation 
and the opportunity to opt out were emphasized, whereas the purpose and anonymity 
of the study was outlined. From both the children and their guardians informed 
passive consent was obtained. The pupils received a short standard oral introduction 
outlining the content of the questionnaire, its anonymity and that participation was 
not mandatory, given by the first author on the day of investigation. The 
questionnaire (Appendix I) included information of age and sex, single questions 
concerning experience with intra-oral injections and avoidance of intra-oral 
injections, in addition to four psychometric self-report instruments: 1) the Intra-Oral 
Injection Fear scale (IOIF-s) (73); 2) the Children's Fear Survey Schedule- Dental 
Subscale (CFSS-DS) (43, 74); 3) the Injection Phobia Scale for children (IS-c) (42) 
and 4) the Mutilation Questionnaire for children (MQ-c) (42). 
 
2.2.2 Study II 
This randomized controlled trial was conducted at the Centre for Odontophobia, Oral 
Health Centre of Expertise in Western Norway, Hordaland, between 2013 and 2016. 
The patients were met by one of the two clinical psychologist in the waiting room 
prior to completion of the psychometric self-report instruments IOIF-s (73), CFSS-
DS (43, 74), IS-c (42) and MQ-c (42). Subsequently, a semi-structured diagnostic 
interview was conducted by the psychologists. Following the interview, patients 
underwent a behaviour avoidance test (BAT) after which they promptly completed 
the questionnaire denoted "Cognitions during the BAT".  
 The randomization process was eventually performed in which the patients 
withdrew a sealed, numbered and opaque envelope randomly allocating them into 
either a treatment group (Group I) or a control group (Group II). Treatment started 
the following week for the immediate treatment group (Group I/ITG), pursuing one 
session per week for 5 weeks (Paper 3, Figure 1). The waitlist-control group (Group 
II /WCG) had a new appointment with the psychologist after 5 weeks on a waitlist. 
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They were re-examined by the psychologist with respect to any possible effect (the 
four psychometric self-report instruments were completed, followed by the BAT and 
"Cognitions during the BAT") prior to eventually being allocated to treatment and 
further included in the treatment group for post-treatment and 1-year follow-up 
assessment. At post-treatment and at 1-year follow-up, all patients (from both groups) 
underwent a short interview by a psychologist, completed the same set of 
psychometric self-report instruments and underwent the BAT including completion 
of the "Cognitions during the BAT" questionnaire. Promptly after post-treatment 
assessments, patients were scheduled for an appointment with a regular dentist at 
their local PDS clinic. An epicrisis describing the conducted CBT treatment and 
recommendations for future dental treatment was attached to the patients’ digital PDS 
journal. Data regarding success of receiving intra-oral injections, both during the 
CBT performed by the specially trained dentists and during the 1-year follow-up 
period with the regular dentist were obtained from the PDS journal. Due to ethical 
reasons dental treatment (e.g., drilling, extractions) following intra-oral injections 
received as part of the CBT, was conducted for the patients that were capable within 
the 5 sessions.  
 Four dentists were performing the treatment, all being specially trained and 
accredited in CBT for I-OIP according to the manual for one-session treatment, 
modified for 5 sessions (61, 63, 67). Three of the dentists had been evaluated and 
approved by Professor Öst, based on videotaped treatment sessions. The fourth 
dentists had equivalently been evaluated and approved according to the same criteria 







2.3 Instruments and measures 
2.3.1 Psychological measures 
2.3.1.1 Intra-oral injection fear 
The Intra Oral Injection Fear scale (IOIF-s) is a 12-item psychometric self-report 
instrument in Norwegian assessing fear of intra-oral injections in children (Appendix 
I). Each response is scored from 1 to 5 (1 = not afraid at all, 5 = very afraid) with a 
sum score ranging from 12 to 60. 
 A Visual Analogue Scale (VAS) was used to evaluate self-perceived fear of 
intra-oral injections (0 = no fear at all; 10 = terrified). 
 
2.3.1.2 Dental fear 
The Children’s Fear Survey Schedule–Dental Subscale (CFSS-DS) is a 15-item 
validated psychometric self-report instrument measuring dental fear in children (43, 
74). Each response is scored from 1 to 5 (1 = not afraid at all, 5 = very afraid) with a 
sum score ranging from 15 to 75. The validated cut-off score of 38 was used to 
indicate high dental fear (16, 48).  
 
2.3.1.3 Fear of injections 
The Injection Phobia Scale for children (IS-c) is an 18-item psychometric self-report 
instrument assessing fear of injections.  Each response option ranged from 0 to 4 (0 = 
not afraid at all, 4 = very afraid) (42). The sum score ranged from 0 to 72. No cut-off 




2.3.1.4 Blood-injury fear 
The Mutilation Questionnaire for children (MQ-c) is a 15-item psychometric self-
report instrument assessing blood and injury fear (42) with five response alternatives 
for each item ranging from 0 to 4 (0 = not afraid at all, 4 = very afraid). The sum 
score ranges from 0 to 60. No cut-of score was validated.    
 
2.3.2 Diagnostic interview  
Intra-oral injection phobia was diagnosed by a semi-structured diagnostic interview 
(lasting 1-1.5 hours) performed by a clinical psychologist according to the DSM-5 
criteria for BII phobia (1). Psychoeducation and behavioural analysis were conducted 
as part of the diagnostic interview, including a brief description of the treatment 
method and its rationale.  
 
2.3.3 Behavioural measures 
2.3.3.1 Behavioural Avoidance Test 
The behavioural avoidance test (BAT) consists of 13 steps progressively approaching 
exposure to an intra-oral injection (Paper 3, Table 1). External dentists blinded to the 
assessment point and group affiliation performed the BATs. An oral introduction was 
given to the dentists on how to perform the test. The dentists were also given a 
written manual. Furthermore, the dentists were informed about the importance of 
standardization and the rationale for the test. The psychologists informed the patients 
about the rationale for the test, conveying that each step was to be verbally explained 
by the dentist. They were further informed that they freely could ask any question 
during the test or discontinue the test at any point. Termination of the test could be 
signaled either verbally or by showing a “No” card. A test was considered a 
successful intra-oral injection if patients completed at least step 10 (“putting a few 
drops of anaesthesia”). 
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2.3.3.2 Cognitions during the BAT 
"Cognitions during the BAT" assessed the frequency of 5 negative and 5 positive 
thoughts on a 5-point Likert scale (0 = Never, 4 = Very often). The negative thoughts 
are “I can’t do this”, “I’m going to fail”, “I’ll faint”, “I need to get out of this 
situation” and “I can’t stand this”. The positive thoughts are “I have control over the 
situation”, “It’s going well – better than I thought it would”, “It’s not as unpleasant 
as I thought”,” I feel calm and safe” and “I’m satisfied with myself”(75). 
 
2.3.3.3 Ability to receive intra-oral injections 
Information on whether the patients were able to receive "successful" intra-oral 
injections during the CBT treatment was obtained by the dental records in the journal 
made by the dentist performing the treatment (Study II). A "successful" intra-oral 
injection corresponded with completion of at least step 10 of the BAT, in line with 
ideal treatment goals. Similarly, information about "successful" intra-oral injections 
during the 1-year follow-up period at the local dentist was obtained from the PDS 
journal. 
 
2.3.3.4 Time since last intra-oral injection  
The participants were asked when they received their last intra-oral injection at the 
dentist (< 1 year ago, ≥1 year ago, never received or cannot remember having 





2.3.3.5 Avoidance of intra-oral injections  
The participants were asked to estimate how sure they were of being able to cope 
with dental treatment knowing that an intra-oral injection was required ("definitely", 
"probably", "probably not", "certainly not") (Study I). 
 
2.4 Treatment 
The applied treatment in Study II was cognitive behavioural therapy (CBT) modified 
for 5 sessions in children, each with a maximum duration of 1 hour as delineated by 
professor Öst (61, 63, 67). Adjustments for maturation and developmental level of 
each individual patient were made. Further, the modifications for treatment of I-OIP 
included addressing its unique or typical characteristics; the pain sensation, the 
feeling of disgust and the vaso-vagal response/fainting. Education regarding the 
association between pain and fear was conducted. Fearful patients have been found to 
report more pain during dental injections than less fearful patients, thus by reducing 
the level of fear the perception of pain is reduced (76). Establishing a good 
therapeutic relationship with a common understanding of the importance of joint and 
balanced contribution was among the main principles for treatment. Furthermore, the 
patients underwent gradual and controlled in vivo exposure to a hierarchy of fear-
provoking steps connected to dental injections (Paper 3, Table 2). The element of 
pain may lead to more graduated exposure steps. During exposure, the patients’ 
catastrophic thoughts and fear symptoms were elicited to explore what happens when 
they are exposed to fear-provoking situations. For patients experiencing the feeling of 
disgust, disgust eliciting exposure tasks were exerted. The dentist helped the patients 
with cognitive restructuring of the thoughts, feelings and fear symptoms. In each 
treatment session, sub-goals were pursued (Paper 3, Table 2). In patients with a 




2.5 Construction of variables 
2.5.1 Study I 
The variable, "Avoiders" were handled differently in Paper 1 and Paper 2. For 
validation of the IOIF-s (Paper 1), when asked if they were able to cope with dental 
treatment knowing that an intra-oral injection was required,  Avoiders were defined 
as those responding "certainly not" whereas Non-avoiders were those responding 
"definitely". The responses "probably not" and "probably" were excluded to avoid 
ambiguous answers during validation of the IOIF-s.  
 In Paper 2, Avoiders were defined as those responding "certainly not" or 
"probably not" whereas Non-avoiders were those responding "definitely" or 
"probably" when asked if they were able to cope with dental treatment knowing that 
an intra-oral injection was required. This dichotomized variable was constructed for 
logistic regression analysis (Paper 2, Table 5 and 6), where the dependent variable 
was “Avoiders” (1)/”Non-avoiders” (0). Independent variables also underwent 
dichotomization. Dichotomization of the variable, “High/Not high fear of intra-oral 
injections" was based on the sum score achieved on the IOIF-s, "High fear" (> sum 
score 38 (1)), "Low fear" (≤sum score 38 (0)). The variable, "High/Not high dental 
fear" was similarly based on the sum score achieved on the CFSS-DS, where "High 
dental fear" (>sum score 38 (1)) and "Low dental fear" (≤sum score 38 (0)). The 
variable, "Sex" was "Girls" (1) and "Boys" (0), and the variable, "Age" was 
categorized into "Youngest" (10-12 years (0)) and "Oldest" (13-16 years (1)). The 
variable, "Experience with intra-oral injections" was dichotomized into "Yes" (1) and 
"No" (0). Participants who responded as having received intra-oral injections " <1 
year ago" or "≥1 year ago" were coded "Yes" (1). Participants responding, "never 
received or can’t remember having received intra-oral injections" were coded as "No" 




2.6 Ethical Considerations 
Ethical approvals from Regional Committees for Medical and Health Research Ethics 
in Norway (REK, 2010/63-3) were obtained for both Study I and Study II. Study II 
was additionally registered at clinicaltrials.gov (NCT02083432). Permission to 
conduct the questionnaire study at schools was obtained from the educational 
authorities and school administrations in each municipality, in addition to informed 
passive consent from both the pupils and their guardians (Study I) (Appendix II). 
Informed written consent from patients and their guardians was collected (Study II) 
(Appendix III).  
 
2.7 Statistics 
Statistical analyses were performed using the Statistical Package for Social Sciences 
(SPSS), version 22.0 (Paper 1 and 2) and 23.0 (Paper 3) (IBM, Armonk, NY, USA). 
Sum scores on the scales were calculated, and sum scores for individuals with 
missing information on 20% or fewer items were hence imputed and the missing 
values replaced using the mean of the other values. The exception was the 
"Cognitions during the BAT", where no missing questions was required for 
computing the sum-score.  
 Leven's test for equality of variances was conducted for the ANOVAs and the 
t-tests. When the assumption of equal variances was violated, the Welch test not 
assuming homogeneity of variances was conducted. Effect size (eta squared) was 
calculated for differences in mean sum scores between groups based on the following 
guidelines: 0.01=small effect, 0.06=medium effect and 0.14=large effect (79). 
Analyses performed are shown in Table 2. 
 In Paper 1, internal consistency reliability of the IOIF-s was analysed by 
Cronbach's alpha, Alpha if Item Deleted, Corrected Item-Total correlation and the 
Inter-Item Correlation coefficients. The Intra Class Correlation (ICC) coefficient was 
used for test-retest analyses. Furthermore, to assess validity, the independent sample 
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t-test was used in comparison with the IOIF-s sum score data between those not 
diagnosed with intra-oral injection phobia (Sample I) and those diagnosed with intra-
oral injection phobia (Sample II). Additionally, an independent sample t-test was 
used to compare differences in the IOIF-s sum score between "Avoiders" and "Non-
avoiders". Relationships between bivariate variables (between the IOIF-s and the 
MQ-c, IS-c, CFSS-DS and the single question rating self-perceived fear of intra-oral 
injections) were analysed with Spearman's correlation coefficients. To further 
emphasize validity, Principal Component Analysis (PCA) with oblimin rotation was 
performed to identify the underlying structure of the IOIF-s. The number of 
components retained was guided by three decision rules: 1) Kaiser's criterion 
(Eigenvalues above 1); 2) inspection of the scree plot (the number of components 
above the change of shape of the plot were retained) and 3) by use of parallel analysis 
(80) (components with eigenvalues exceeding the values obtained from 
corresponding random data sets were considered separate components). A Receiver 
Operating Characteristics (ROC) curve was used to determine the most discriminant 
IOIF-s cut-off score (Paper 1, Fig. 1). This was done in order to separate those with I-
OIP from all others, with the best balance between sensitivity and specificity (81). 
 In Paper 2, one-way analysis of variance (ANOVA) was used to analyse group 
differences. To assess relationships and differences between groups of subjects with a 
high level of fear of intra-oral injections and those with a high level of dental fear, 
Chi-square tests with Yates Continuity Correction were employed. Furthermore, 
logistic regression models were utilized to assess associations between the dependent 
and independent variables. Bivariate and multiple (standard) analyses were 
conducted, yielding Odds Ratios (ORs) with 95% Confidence Intervals (CIs). 
Pearson's correlation coefficients were conducted to assess multicollinearity between 
the independent variables. 
  In Paper 3, a mixed between-within subjects ANOVA for repeated measures 
was used to test whether treatment was better than wait-list control by comparing the 
ITG with the WCG. The factors were group (ITG and WCG) and time (pre- and post-
treatment/waitlist). Additional sensitivity analyses were performed to examine the 
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impact of drop-outs following the intention-to-treat (ITT) principles, using the last 
observation carried forward to post-treatment/post-waitlist. To combine the WCG 
with the ITG, two further analyses were made comparing the immediate and the 
delayed treatment groups within each condition: 1) independent sample t-tests 
between pre-treatment scores in the ITG and the WCG and 2) paired sample t-tests of 
score changes in the WCG (degree of change from pre- to post-waitlist). The 
immediate and delayed treatment groups were combined for further analyses if no 
significant differences were found. To analyse time changes (pre- and post- treatment 
and at 1-year follow-up), paired sample t-tests were used.   
 
Statistics and methods used Paper 1 Paper 2 Paper 3 
Principal Component Analysis +   
Chi-square statistics  +  
Cronbach’s alpha +   
Alpha if Item Deleted  +   
Inter-Item Correlation coefficients +   
Corrected Item-Total correlation +   
Intra Class Correlation coefficient +   
Effect size statistics + + + 
Logistic regression (OR)  +  
Paired sample t-test    + 
Independent-sample t-test +  + 
One-way ANOVA  +  
Repeated measure ANOVA (mixed between-within 
subjects) 
  + 
Spearman’s rank correlation coefficient +   
Pearson correlation coefficient + +  








3.1.1 Study I 
In total, 1460 pupils aged 10- to 16 years were invited to participate in the study. 
Because 19 pupils declined to participate in the study, the final sample consisted of 
1441 pupils (Paper 1, Table 1), yielding a response rate of 98.7%. Furthermore, 13 
had not completed the question regarding sex and in the remaining sample, 50.9% 
were girls (727 girls and 701 boys) (Paper 2, Table 1). The mean age of the 
participants was 12.7 years (SD=1.9). Altogether, 31 schools participated in the study 
(33.7% of the invited schools). 
 
3.1.2 Study II 
In total, 67 patients (39 of which were girls) (Table 3) were enrolled in the study 
within the time limit for enrolment. The mean age of the participants was 12.2 years 
(SD=2.0, age range 10-16). In total, 58 patients completed the CBT treatment and 
attended the accompanying post assessments, whereas 4 patients in the immediate 
treatment group (ITG) did not complete treatment and 5 patients dropped out of the 
waitlist control group (WCG), yielding a response rate completing the treatment of 
86.6%. Furthermore, 54 patients attended the 1-year follow-up assessments, whereas 
4 of the patients completing the post-treatment assessments failed to appear (response 
rate 80.6%) (Paper 3, Figure 1).   
 One patient that discontinued the CBT was, by conjoint judgement 
between dentist and patient/guardian, scheduled for further dental treatment under 
general anaesthesia as the patient did not respond sufficiently to the CBT. Another 
patient was found to need more treatment sessions at the psychologist prior to the 
CBT. Hence these patients were considered drop-outs from the study. The remaining 
11 drop-outs were due to unknown reasons. Furthermore, of the patients considered 
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drop-outs, 2 were diagnosed with respectively Attention Deficit Hyperactivity 
Disorder (ADHD) and Asperger syndrome, and 2 were enrolled in psychiatric out-
patient clinics for unknown reasons. Among the remaining sample completing the 
treatment and follow-up assessments, 4 were diagnosed with ADHD whereas 2 
patients were under further consideration by psychologists due to attention, 
concentration and behavioural problems. Additionally, 1 patient was after fulfilling 














Table 3. Distribution of participants according to sex and age (Sample II). 
Age (yr) Girls Boys Total 
10 10 5 15 
11 6 7 13 
12  7 5 12 
13 4 5 9 
14 5 2 7 
15      7      1      8 
16 0 3 3 
Totalt 39 28 67 
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3.2 Results, papers 
3.2.1 Paper 1 (Study I and Study II) 
3.2.1.1 Reliability 
The internal consistency reliability of the items in the IOIF-s yielded a Cronbach's 
Alpha coefficient of 0.95. The test-retest revealed an ICC of 0.79 (95% CI: 0.53-
0.90). Furthermore, the corrected item-total coefficient ranged from 0.59 to 0.88 
(Paper 1, Table 2), whereas the inter-item correlations ranged from 0.38 to 0.86 
(Paper 1, Table 3). The results yielded satisfying reliability. 
 
3.2.1.2 Validity 
Validity was shown in that the IOIF-s discriminated significantly between the 
participants with and without a diagnosed I-OIP (participants in Study I and Study II). 
Furthermore, the IOIF-s total score was found to discriminate significantly between 
non-avoiders and avoiders of intra-oral injections, supporting the construct validity of 
the scale. 
 The correlation coefficient between the sum score of the IOIF-s and the 
participant single question rating of self-perceived fear of intra-oral injections was 
significant (rho=0.78, p<0.001). Furthermore, the IOIF-s was associated with other 
survey instruments of similar construct. A significant correlation was found between 
the sum scores of the IOIF-s and IS-c (rho=0.83, p<0.001), and between the sum 
scores of the IOIF-s and MQ-c (rho=0.65, p<0.001). A significantly stronger 
correlation was found between the IOIF-s and IS-c than between the IOIF-s and the 
MQ-c (Z=10.94, p<0.001). 
 Principal Component Analysis of the IOIF-s revealed a two-component 
solution characterized as "Contact Fear" and "Distal Fear". Examination of the 
content of the items found that the "Contact Fear" items all shared the common 
characteristics of actual contact with the intra-oral injection. The "Distal fear" items 
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shared the characteristics of all being indirectly or remotely related to contact with 
intra-oral injections. This two-component solution was supported by the fact that 
these components revealed eigenvalues exceeding 1 (7.7 and 1.02, respectively) 
(Paper 1, Table 4). The structure matrix providing information about the correlation 
between variables and factors and the unrotated loadings (Component Matrix) is 
presented in Table 4. With 0.4 as a basis for salient loading, inspection of the pattern 
matrix revealed no items with loadings on multiple components, whereas both 
components had items with salient loadings. In total, 72.7% of the total scale variance 
(64.2% and 8.5%, respectively) was accounted for by the two components.  The scree 
plot indicated a break after the second component (Figure 1). Parallel analysis 
revealed one component with eigenvalues exceeding the corresponding criterion 
value for a randomly generated data matrix of the same size. The first random 
eigenvalue generated by the parallel analysis was 1.15 and the second value was 1.11. 
























 Structure Matrix Component Matrix 
 
 Comp. 1 Comp. 2 Comp. 1 Comp. 2 
Item: 









IOIF item 2   .914  .552 .878  -.262 
IOIF item 1   .907  .581 .881  -.217 
IOIF item 7   .886  .553 .855  -.231 
IOIF item 11   .861  .593 .848  -.154 
IOIF item 3  .768  .687 .804   .065 
IOIF item 10  .766  .451 .731   -.234 
IOIF item 9  .765  .632 .786   -.002 
IOIF item 4  .756  .681 .793   .071 
IOIF item 5  .604  .881 .735   .488 
IOIF item 6  .511  .849 .653   .546 
IOIF item 12  .597  .820 .711   .418 
Table 4. Structure and Component matrix for the IOIF-scale. Rotation converged 
in 5 iterations (Sample I). 
Figure 1. Scree plot: Each of the eigenvalues of the components plotted 
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3.2.1.3 Receiver Operating Characteristics 
The Receiver Operating Characteristics (ROC) curve, used to determine the most 
discriminant IOIF-s cut-off score, indicated that a cut-off score of 38< was 
appropriate (Paper 1, Fig. 1). The ROC-curve revealed that by dichotomizing the 
IOIF-s at a cut-off score of 38, I-OIP was detected with a sensitivity of 0.61 and a 
specificity of 0.85, and an Area Under the Curve (AUC) of 0.73 (95% CI:0.66;0.80 
p<0.001). 
 
3.2.2 Paper 2 (Study I) 
3.2.2.1 Prevalence of BII fear and dental fear  
A total of 59.4% of the children could remember having received an intra-oral 
injection at some point, and 31.1% could remember an injection within the past year. 
The mean scores for the scales IOIF-s (27.5 and 19.7), CFSS-DS (28.3 and 22.3), 
MQ-c (17.3 and 10.2) and IS-c (18.4 and 9.7) were significantly higher for girls 
compared to boys (Paper 2, Table 2). However, among those who scored above cut-
off at the IOIF-s, no significant sex differences were found. Furthermore, the mean 
IOIF-s sum score revealed significantly higher values for the youngest age group (10-
13 years) compared to the oldest (14-16 years), with respective means of 24.7 and 
22.5. However, the effect-size analyses revealed that the age difference was small. In 
total, 13.9% of the children reported high intra-oral injection fear, including 21.1% of 
girls and 6.4% of boys. The corresponding percentages for dental fear were 11.7%, 
including 17.1% for girls and 6.4% for boys. There were significant associations 





3.2.2.2 Overlap between intra-oral injection fear and dental fear 
A significant relationship was found between fear of intra-oral injections and dental 
fear. Of the children reporting high fear of intra-oral injections, 57.7% also reported 
high dental fear, while 66.3% of those reporting high dental fear also reported high 
fear of intra-oral injections. In total, 7.9% of children reported both high fear of intra-
oral injections and high dental fear.  
 
3.2.2.3 Avoidance of intra-oral injections 
When an intra-oral injection was needed, 10.6% reported that they probably would 
avoid dental treatment. The reported OR values in bivariate analyses for intra-oral 
injection fear, dental fear and experience with intra-oral injections were 12.7, 10.5 
and 0.4, respectively, and each was significantly associated with Avoiders (Paper 2, 
Table 5). In multiple regression analysis, high intra-oral injection fear was found to 
predict avoidance of dental treatment with a peak OR of 6.5 (Paper 2, Table 6). 
 
3.2.3 Paper 3 (Study II) 
3.2.3.1 Immediate treatment group (ITG) vs waitlist-control group (WLC) 
The results showed that CBT had a significant effect compared to no treatment, on all 
self-report measures (Paper 3, Table 3), except for positive thoughts, in which neither 
of the groups revealed a significant effect. The results of the ITT analysis yielded no 
differences in significance level apart from three exceptions. At the IS-c, the 
significance level at the group effect was altered from not significant to a significance 
level of p<0.05, whereas regarding the BAT and negative thoughts, the significance 




3.2.3.2 The effect of CBT in the group as a whole 
In the group as a whole, a significant reduction from pre- to post-treatment was found 
on all four psychometric instruments (Figure 2). The results for the IOIF-s, CFSS-DS 
and IS-c were maintained from post-treatment to 1-year follow-up, whereas the MQ-c 
revealed further significant reduction. Furthermore, significantly more steps of the 
BAT were completed post-treatment compared to pre-treatment for the group as a 
whole, and the effect was maintained from post-treatment to follow-up. Similarly, 
treatment significantly reduced the frequency of negative thoughts from pre- to post-
treatment, whereas the positive thoughts remained unchanged. The results were 





Figure 2. Study II: Mean sum scores of the Intra-Oral Injection Fear scale (IOIF-s), Children's Fear 
Survey Schedule-Dental Subscale (CFSS-DS), Injection Phobia Scale for children (IS-c) and 
Mutilation Questionnaire for children (MQ-c) according to assessment time;  pre-treatment (Pre), 









3.2.3.3 Ability to receive intra-oral injections 
Of the 67 patients originally enrolled in the study, 70.1% managed to receive intra-
oral injections during CBT treatment. Another 14.9% managed to have a few drops of 
anaesthesia injected in submucosa, but not the fully required amount. After 
completing the CBT, 49 of the patients were in need of further dental treatment at 
their local dental clinic. Of these patients, 69.4% managed to receive the necessary 


















4.1 Methodological considerations 
4.1.1 Sample size and representativeness 
4.1.1.1 Study I 
The high response rate among the pupils strengthened the representativeness of data 
for Hordaland County, even though a strike among teachers led many of the schools 
to decline participation. As the teacher strike reached a national level and affected 
public elementary schools regardless of area and demographic characteristics, it can 
be assumed that the impact on outcome measures was probably limited. The 
standardized procedure in which the survey was conducted, further added support to 
the representativeness. Nevertheless, the sample was limited to only one Norwegian 
county and thus was not representative of all Norwegian pupils within this age range. 
The structure of the public dental service (PDS) and the public school system in the 
county is based on national guidelines. The PDS in Norway is free of charge for all 
children within this age range, and approximately 97.5% of all children attend public 
elementary schools (82). It is therefore reasonable to believe that the results are 
indicative of the situation for the targeted age group in Norway. Only 19 pupils 
declined to participate in the study, yielding a high response rate at the individual 
level within the schools. This could partly be explained by use of informed passive 
consent rather than written consent. This type of consent highly limits selection bias, 
but introduces some ethical issues. However, permission to use passive consent was 
granted by the ethics committee (REK) as the questionnaire was of a character such 
that ethical integrity was ensured.         
 A similar study with focus on BII phobia randomized the study 
population by municipality classes (26). As classical conditioning is known to be one 
of the most important factors in the acquisition of BII phobia (13, 69, 70), the present 
study sampling was instead based on public dental clinics. Schools belonging to the 
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catchment areas of the largest public dental clinic were first invited, as the intention 
was to minimize the effect of single dentists treating all pupils in one area. 
Nevertheless, all six municipality classes present in Hordaland County were 
represented in the final sample. The participating school classes within each school 
were selected by the respective headmasters and teachers in each school. This 
selection was based on availability and convenience that particular day, thus leaving 
the selection not truly random, but rather somewhat arbitrary. Another limitation was 
the fact that the data were analysed with the single pupil as the entity for analyses. 
Although the pupils were sitting at their respective desks in classrooms while 
completing the questionnaires, the analysis did not take into account the possible 
influence that pupils have on each other. However, the fact that the author was 
present in the classroom to give the standard introduction about the questionnaire and 
study most likely increased the reliability of the study. The author's main impression 
was that the pupils participated mostly in a conscientious manner. 
 As a relatively large sample was required to detect differences 
among sex and the two selected age groups, significant results were followed by 
effect size statistics. Because the effect size indicates the magnitude of the effect, this 
step was taken to limit relevance of statistically significant results that were not 
clinically relevant due to the large sample size (71).   
 
4.1.1.2 Study II 
Despite the relatively small sample size, power analysis confirmed that there was 
adequate power to detect differences between the treatment group and the control 
group (71). In terms of sample size and power, this study was in line with other CBT 
studies (67, 83, 84).  
 The patients were all referred from the PDS because they were not 
able to receive the intra-oral injections required to undergo necessary dental 
treatment. The patients were not self-referred, and 97.9% of all children (aged 1-18, 
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2014) in Norway, regardless of socioeconomic background were under regular 
supervision of PDS (85). Hence, there are reasons to believe that the sample of Study 
II, to some extent, can be indicative for children with I-OIP in the general population 
of Hordaland. A limitation to this statement is that some of the phobic children may 
be compelled through dental treatment by the dentist or parents against their will. 
Furthermore, the dentist may have postponed further dental treatment until the child 
has matured so that children were not being referred to the Centre for Odontophobia. 
Additionally, children and/or guardians may have declined the offer of referral for 
cognitive behaviour therapy (CBT). However, it was a prerequisite before treatment 
with general anaesthesia that all guardians/dentists either had considered or had 
attempted referral of children to the Centre for Odontophobia.       
 Because ethical considerations made it impossible to recruit patients 
either for a control condition that implied no treatment or for a condition of known 
ineffectiveness, the patients were allocated to a five-week long waitlist (Waitlist-
Control Group). The time for which treatment was withheld was chosen as it 
corresponded to the duration of treatment for the patients in the Immediate Treatment 
Group (ITG). It was hypothesized that 5 weeks of CBT would result in reduced fear 
of intra-oral injection among the ITG. Therefore, any reduction in fear within 5 
weeks among the Waitlist-Control Group (WCG) would be valuable information 
regarding the actual effect of CBT. Additionally, 5 weeks was regarded appropriate 
as the patients would probably not remember their answers between the first and the 
second assessment. Accordingly, the replicate measurement should be independent of 
the first measurement. Furthermore, the relatively short amount of time between the 
assessments limits the time in which patients may be influenced by external factors 
which may influence their phobia (86). The WCG was implemented because previous 
research has shown that the rate of significant remissions from specific phobias was 
found to be very low without any exposure to the phobic stimuli (87, 88). In general, 
the design with a WCG is considered to be an accepted design for clinical treatment 
studies (86).  
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 A strength of the study was that there were four dentists who carried 
out the CBT, who all had underwent calibration procedures for the specific study. 
Furthermore, two psychologists performed the interviews. 
 
4.1.2 Instruments and measures  
4.1.2.1 Assessing intra-oral injection fear, Intra-Oral Injection Fear scale (IOIF-s) 
The BII phobia has been reported to have an onset prior to 10 years of age (5-7). The 
early onset, combined with the consequences of avoidance of intra-oral injections 
such as poor pain control during dental treatment, contributes to dental fear (89-92). 
Hence, the need for early and correct identification of intra-oral injection fear was 
emphasized. The satisfying psychometric properties in terms of reliability and 
validity of the IOIF-s made it useful for evaluation of intra-oral injection fear both at 
a population and at an individual level. 
 To identify the underlying structure of the IOIF-s and to summarize 
the data using a smaller set of factors or components, a principal component analysis 
(PCA) was conducted. PCA was chosen rather than a confirmatory factor analysis, as 
the latter is applied when a hypothesis exists about expected factor structures. The 
PCA is one of the methods preferred if the purpose is to explore the data without a 
prior hypothesis or model. This was the case, as the IOIF-s was not known to be 
based on a theoretical assumption of specific separate dimensions and no prior factor 
structure model existed. Oblique rotation was performed as it was considered that if 
more than one component were revealed, they could be correlated. Using an oblique 
rotation method is recommended in psychological research as it is reasonable to 
expect correlations between components (93). Although indistinct demarcations were 
found by the PCA, a two-dimensional structure was revealed, consisting of "Contact 
Fear" and "Distal fear". The former accounted for the strongest part of intra-oral 
injection fear (Paper 1, Table 4). A one-component structure also had to be 
considered due to the somehow indistinct demarcations. However, an overall 
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evaluation of the PCA in combination with theoretical coherence favoured the two-
component structure. The strength of the component loadings and the high 
communalities increase the certainty of the results of the PCA, indicating that the 
components are stable (94). A similar two-component structure, labelled "Contact 
Fear" and "Distal Fear" have been found in two other scales assessing, respectively 
injection fear in children (IS-c) and Injection Phobia Scale-Anxiety (IPS-Anx), 
assessing injection fear in adults (42, 95). 
 The cut-off value was chosen for the IOIF-s to separate persons with 
high intra-oral injection fear from persons with low- and moderate- intra-oral 
injection fear. This cut-off value demonstrated moderate discriminative properties. 
The area under the curve (AUC) can be interpreted as the probability that the test will 
yield a score in the elevated/abnormal range for a randomly chosen person who has 
been diagnosed with intra-oral injection phobia compared to a randomly chosen 
person who has not been correspondingly diagnosed. The AUC of 0.73-0.87 revealed 
in Paper 1 corresponds to a moderate level (81, 96). Although a cut-off point nearest 
the upper left corner results in the smallest overall error rate, other factors may make 
it preferable to adjust this point (81). In this case, the cut-off point was increased. As 
a consequence, the specificity was increased while the sensitivity was decreased. 
From a clinical and research perspective, it can be argued that specificity in this case 
is more important with respect to the nature of fear, anxiety and phobia (1, 11), which 
emanate from a continuum. A lower cut-off value would increase both the sensitivity 
and the likelihood of Type 1 error. All patients diagnosed with intra-oral injection 
phobia by the psychologist in Study II scored above 38 on the IOIF-s (mean score 
40.1) before treatment, which further supported the cut-off value chosen. A limitation 
of the chosen cut-off value is that the number of participants in Study II assessed by a 
psychologist was relatively small, whereas the participants in Study I, which was a 
large sample with a high response rate, were not assessed by a psychologist. A larger 
diagnosed sample in which all participants were assessed by a psychologist for 
diagnosis with or without intra-oral injection phobia, might have altered the results of 
the ROC curve and thereby the cut-off point (81). Additionally, validating the cut-off 
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scores according to child and adolescent ages and sex could further improve the 
validity of the cut-off score (16, 81). This should be focused on in further studies.   
 A method used for determining cut-off scores in psychometric 
measures is a value one standard deviation (SD) above the mean as the cut-off score 
for self-reported fear in children (97). For the IOIF-s, that would imply a cut-off score 
of 34.9, which is lower than the standard cut-off score revealed in Paper 1. However, 
this method provides no information about the scale sensitivity and specificity. Due 
to these factors, the cut-off score chosen for the IOIF-s seems to be a relevant 
standard cut-off score to detect those in need for special attention. Nonetheless, it 
should be interpreted with caution.   
 
4.1.2.2 Dental fear and BII fear 
The CFSS-DS is a validated psychometric instrument for assessing dental fear in 
children which has been widely used, and found to have good reliability and validity 
in different populations, including that of Scandinavia (4, 43, 74, 98, 99). The 
instrument may be used in two different versions, either by self-rating by the child or 
by parental ratings. Self-ratings by the children were used in this thesis to strengthen 
the reliability and validity, as scales completed by parents/guardians have shown 
moderate agreement between child and parental ratings on self-reports (16). For the 
child version, cut-off scores between 37 and 42 have been used (16, 48, 100). In the 
present thesis, the score above 38 was chosen for both Study I and II, similar to the 
cut-off score used in a Swedish study (containing a small sample with child self-
ratings) (16). Another study used one standard deviation (SD) above the mean as a 
cut-off value when children completed the CFSS-DS (97). If this method had been 
used in the present study, it would have lowered the cut-off value and consequently 
would have increased the prevalence of dental fear. Furthermore, different cut-off 
scores by age and sex for the parent rated CFSS-DS scale have revealed cut-off 
scores lower than the standard cut-off scores (16). Accordingly, the use of standard 
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cut-off scores in the prevalence estimation of dental fear might have underestimated 
the fear level. 
 The IS-c and MQ-c assessing fear of injections and blood-injury fear 
in children, respectively, were constructed and validated in a Swedish sample of 8- to 
17-year-old children and adolescents (N=677). In the study, norm data were obtained 
and psychometric properties were evaluated (42). Both scales had excellent 
psychometric properties and were found to be appropriate for use both in research 
and as a clinical tool. A limitation was that the scales did not have a validated cut-off 
score for measuring a high level of fear.  
 The IS-c, MQ-c and CFSS-DS were all in Norwegian. The 
Norwegian versions were based on the Swedish versions, as the two Scandinavian 
languages are closely related to each other. The scales had been translated from 
Swedish to Norwegian and were then back-translated.   
 Even though psychometric self-report scales are recommended for 
assessing fear in children, and widely used, the validity of using self-reported scales 
in 10- to 16-year-olds must be interpreted with caution. Their responses depend not 
only on their age, but also on their stages of development in cognitive, social and 
emotional terms (101).   
 
4.1.2.3 Behavioural Avoidance Test  
The BAT (Paper 3, Table 1) was used to measure behavioural changes, and has 
previously been used in adults (67). Similar versions adapted for specific phobias 
including other BII phobias have been utilized for both children and adults (66, 70). 
As avoidance is known to be one among other important diagnostic criteria of a 
phobia, measures of change in avoidance behaviour are considered useful for 
assessing this disorder. However, the BAT used in this study involved the invasive 
and possibly painful procedure of intra-oral injection. Combined with the lack of an 
established therapeutic alliance to the external dentist, the test may be experienced 
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differently for children than for adults, possibly due to differences in cognitive 
development. As trust and a therapeutic alliance are key aspects during CBT (63, 
101), further research should evaluate whether the BAT for intra-oral injection phobia 
in children is developmentally appropriate.   
 
4.1.2.4 Cognitions during the BAT 
The "Cognitions during the BAT" was assessed in order to evaluate cognitive 
changes that occurred together with behavioural alterations after teatment. Although 
the reliability and validity of the "Cognitions during the BAT" was found satisfactory 
in adults (67), the questionnaire was not necessarily developmentally appropriate for 
children. One may speculate as to whether some of the youngest children may have 
had difficulties differentiating between the present situation and future events when 
responding to the questionnaire. This could possibly have led to conservative results 
of the positive and negative cognitions during the test. 
 
4.1.2.5 Time since last intra-oral injection 
The variable "time since last intra-oral injection" introduces possible recall bias. 
Therefore, the response options <1 year ago and ≥1 year ago were combined, yielding 
the variable "experiences with dental injections". The response options were 
dichotomized into "yes" and "no", to limit recall bias and increase reliability. Most of 
the pupils (59.4%) (Study I) could remember having experienced an intra-oral 
injection. Correspondingly, the PDS in Hordaland County reported the percentage of 
10- to 16-year-olds in 2014with no prior caries experience to be approximately 47%. 
This percentage adds support to the validity of the pupils reported experience with 
intra-oral injections. However, among those who reported not having experienced an 
intra-oral injection or those who did not recall one, some may actually have received 
intra-oral injections. The recollections by these children may be influenced by a 
variety of factors. If the situation was not perceived as particularly fearsome, the 
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children could have forgotten about it. On the other hand, if the situation was 
perceived as extremely fearsome, some children could have supplanted the 
experience or could have dissociated, resulting in not remembering the intra-oral 
injection experience (13).  
 
4.1.2.6 Avoidance 
Avoidance is one of the most important behavioural measures associated with a 
specific phobia (1). Within Paper 2 it was determined to include those who probably 
or certainly would not be able to cope with dental treatment if an intra-oral injection 
was needed. Self-reports, especially on behaviour and particularly among children, 
should be interpreted with caution. Social desirability biases may occur as some 
children tend to answer questionnaires according to what is considered "preferable" 
(102), possibly causing them to under-report avoidance. The anonymity of the study 
was outlined in attempt to limit this effect. Furthermore, completing the questionnaire 
in a classroom, at a distance from the actual exposure to intra-oral injections in a 
dental clinic, may be a challenging transfer of context for the youngest children. The 
youngest children are more dependent on their parents'/guardians' decisions 
concerning dental appointments and treatment, which may have influenced their 
response to this question. This variable was therefore targeting the treatment situation 
involving the intra-oral injection rather than attendance at the treatment session, 
which the children are perhaps not in the position to avoid. However, this 
approximation may introduce some biases, such as possibly including patients more 
afraid of dental procedures other than intra-oral injections (e.g., drilling). 
Nevertheless, this variable probably represents one of the closest approaches for 
assessing self-reported avoidance of intra-oral injections among young children.  




4.2 Prevalence of high intra-oral injection fear 
High intra-oral injection fear based on the IOIF-s was found to be prevalent among 
10- to 16-year-olds in Hordaland County. In Study I, there was a significant tendency 
toward declining intra-oral injection fear with increasing age. The effect size 
statistics, on the other hand, showed that the magnitude of the differences was small, 
implying no strong clinically relevant age influence (71). Previous studies on BII 
fear/phobia and dental fear/phobia in children have shown an inconsistent age effect. 
Several studies have shown dental fear to decrease with increasing age (4, 40, 74, 97, 
100, 103, 104). However, as in Study I, some of these associations were not very 
strong or the effect size was not calculated. Other studies did not reveal any age 
differences (105, 106). Furthermore, the sampling procedures may introduce biases 
(102), as may e.g., different cut-off scores and different informants (child vs proxy), 
making it challenging to compare the results (107).  
 An important factor for interpretation of the results is the element of 
developmental change and maturation of cognitive abilities over time. The results 
may be influenced by the age range from which the study samples are obtained and 
may be dependent on the breadth of the age range. Studies have found that cognitive 
maturation is not necessarily linear over time (108), causing the age range to become 
particularly important when interpreting results and comparing studies. In Study I, a 
larger sample size allowing us to look at differences between each separate age group 
could have influenced the result.                 
 Significant sex differences were found on all four psychometric 
scales. Some of the aetiological factors found to affect and possibly explain some of 
these sex differences include biological factors, vulnerability and environmental 
influences (109). The results revealed in Study I are in line with previous studies of 
BII fear and dental fear in children and adolescents, in which girls were found to 
exhibit both more and a greater intensity of fears than boys (48, 110). However, other 
studies did not reveal any significant sex differences (4, 104). Additionally, girls and 
boys have been found to disclose emotions differently. Accordingly, the fact that girls 
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tend to express fears more freely and truthfully than boys on self-report measures 
should also be taken into account (108).  
  Thus, the underlying reasons for age and sex differences and 
therefore the different prevalence results should be kept in mind when interpreting the 
results. From the clinical perspective, the risk of overlooking the need of some 
patients for extra attention should be considered in particular. 
 
4.3 Overlap between intra-oral injection fear and dental fear 
The strong overlap between those highly fearful of intra-oral injections and those 
highly fearful of dental treatment indicated an association between intra-oral injection 
fear and dental fear among children and adolescents. This was further supported by 
the finding that pupils with a high level of intra-oral injection fear reported 
significantly higher mean scores on the CFSS-DS scale compared to those with a low 
level of intra-oral injection fear (Paper 2, Table 3). As the correlation between the 
scales assessing intra-oral injection fear (IOIF-s) and dental fear (CFSS-DS) was as 
strong as the correlation between the scale assessing intra-oral injection fear (IOIF-s) 
and injection fear (IS-c) (the latter two assessing similar constructs), this adds further 
support indicating a relationship between intra-oral injection fear and dental fear.  
The coincident high dental fear and BII fear levels indicate that the entities are linked 
(40, 52-54).  Previous findings in other age groups revealed similar results in the 
overlap between BII fear and dental fear (38, 58). 
 As Study I is cross-sectional, it cannot determine causal relations. 
However, it is reasonable to believe that patients avoiding intra-oral injections are at 
greater risk of undergoing painful dental procedures. Pain and negative dental 
experiences are known to be risk factors for developing high dental fear (2, 37, 92). A 
higher proportion of those with high dental fear also had high intra-oral injection fear, 
compared to the proportion of those with high intra-oral injection fear who also have 
high dental fear. This adds support to the idea that BII fear could precede dental fear. 
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Additionally, dental phobia has been found to have an onset prior to 12 years of age 
which is later than the other BII phobia subtypes (5). A possible clinical implication 
of these findings suggests that intra-oral injection fear should be addressed before 
treatment of dental fear. 
 
4.4 Consequences of high fear of intra-oral injections 
To evaluate the possible consequences of high fear of intra-oral injections in terms of 
avoidance of dental care, multiple logistic regression analyses were conducted. Intra-
oral injection fear was found to be the main predictor of avoidance of dental 
treatment when an intra-oral injection was needed. This finding adds further support 
to the suggestion of addressing intra-oral injection fear prior to treatment of dental 
fear. Additionally, dental fear and prior experience with intra-oral injections were 
associated with avoidance. A limitation of the analyses was that the variables 
representing intra-oral injection fear and dental fear were highly correlated. 
Nonetheless, as the correlation coefficient was considered not too strong, and because 
both variables were considered important to the analysis, both variables were 
included. The fact that no prior experience with intra-oral injections was found to 
predict avoidance may reflect on the finding that this group probably also contains 
avoiders. Additionally, younger children, found to have a higher level of intra-oral 
injection fear, may not have as much dental experience as older children due to a not 
yet developed need for treatment.    
 In total, approximately ten percent of the participants in Sample I 
were characterized as "Avoiders", yielding a figure higher than a previous similar 
study revealing 3.3% "Avoiders" among 18-year-olds (58). As avoidance is strongly 
associated with intra-oral injection phobia (1), it could be speculated on whether the 
proportion may reflect the prevalence of intra-oral injection phobia. The figure is in 
line with previous studies among 10-11-year-olds (40). However, the limitations of 
the validity of the "Avoidance" variable should be kept in mind. 
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4.5 Treatment of intra-oral injection phobia 
Although CBT has been shown to be effective in treating adults suffering from intra-
oral injection phobia (67), no previous study has been published with focus on 
children and adolescents. The effectiveness of CBT on children and adolescents 
diagnosed with I-OIP performed by specially trained dentists was explored in Study 
II in terms of both self-reported fear and behaviour. The main findings were that CBT 
conducted in only 5 hours was effective for patients diagnosed with I-OIP. This 
outcome was indicated as the results revealed lowered scores both in the self-report 
scales assessing BII fear and dental fear, and altered behaviour assessed by the BAT, 
at post-treatment and at 1-year follow-up. Additionally, the children's ability to 
receive injections both during CBT treatment and at their local PDS clinic during a 1-
year follow-up period indicated behavioural change and successful treatment of the I-
OIP.  
 The fear levels on all four psychometric scales were significantly 
reduced. However, the largest reduction in effect size was found on the IOIF-s. The 
fear level of the IOIF-s was reduced from above the cut-off, to a level substantially 
lower than the cut-off post-treatment. The frequencies of negative thoughts during the 
BAT were also largely reduced, which may be interpreted as the result of patients 
experiencing increased control in the situation as well as partly due to a reduction of 
catastrophic thoughts as a consequence of exposure and psychoeducation during 
CBT. Another important finding was that the patients demonstrated improvements on 
the BAT, from being unable to receive an intra-oral injection pre-treatment, to having 
a "successful injection" post-treatment. Even though the patients did not undergo a 
full diagnostic interview post-treatment and at 1-year follow up, it could be 
speculated on whether these improvements in both behaviour and on the self-report 
scales may imply that the patients no longer fulfilled the criteria for a diagnosis of I-
OIP.  
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 Previous studies have reported that motivation and credibility of 
CBT is essential for the treatment outcome (63, 111). However, due to the level of 
cognitive maturation, children may be less able to understand the treatment rationale.  
Additionally, they are more dependent on parent/guardian motivations and decisions 
for treatment (112). As cognitive maturation and development may cause the 
cognitive appraisal of motivation and treatment credibility to be different for children 
than among adults, these issues were not considered to be inclusion/exclusion criteria 
in this study. Neither were patients diagnosed with ADHD or Asperger syndrome 
excluded from the study. An association has been found between ADHD and BII 
phobia (113). Furthermore, within the targeted age group, not all children have been 
diagnosed despite their condition, leaving no certainty of actually excluding those 
with ADHD and Asperger syndrome. This was reflected in Study II as 1 patient was 
diagnosed with Asperger syndrome within the 1-year follow-up assessment, whereas 
2 patients were under further consideration by psychologists due to attention, 
concentration and behaviour problems. By exerting stricter inclusion and exclusion 
criteria in terms of motivation, ADHD and Asperger syndrome, attrition could have 
been limited and treatment outcomes possibly improved. Regardless, however, 
stricter inclusion/exclusion criteria would leave some children and adolescents 
suffering from intra-oral injection phobia with limited treatment options. 
Additionally, this approach yields a treatment tested in a sample reflecting the 
spectrum of patients actually being referred and in need for help.  
 A previous study has found BII phobia to yield a less favourable 
treatment response compared to other specific phobias (61). However, the findings in 
Study I (Paper 3) are in line with previous studies of similar treatments for other 
specific phobias in children that showed 50%-60% of adolescents are diagnosis-free 
at follow-up (59, 60, 66). One of the most important characteristics of this study 
compared to other studies of the BII phobia was collaboration between health 
professionals. The fact that the main therapist was the dentist and not the psychologist 
facilitated exposure therapy in vivo. Hence, it is likely to believe that post-graduate 
courses in elements of CBT would enable paediatric dentists to treat children and 
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adolescents with moderate and severe levels of intra-oral injection fear (114).  This is 
further facilitated by the short duration of treatment.  
 Specific phobias such as I-OIP are influenced by a number of 
different elements such as vulnerability, psychological preparedness and cognitive 
maturation (20, 22, 40). Additionally, as BII phobia has a heterogeneous presentation 
in children and adolescents, a more individualized number of treatment sessions for 
children rather than the limit of 5 sessions of CBT presented in Study II might have 
further improved the results. Based on the results of this study, CBT performed by a 
specially trained dentist represents an effective treatment of intra-oral injection 
phobia. The author suggests that with an individualized number of treatment sessions, 
CBT is a recommended treatment and should be offered to children and adolescents 
suffering from intra-oral injection phobia. 
 
4.6 Future research 
CBT was found to be efficient for the treatment of I-OIP in children and adolescents 
(Paper 3). However, there is a lack of knowledge on which elements of the therapy 
that are most efficient. As pre- and post-treatment assessments restrict the evaluation 
of therapy to when treatment is over, it is important to know what changes during 
treatment, to detect what causes these changes and how the patient functions during 
treatment. As these elements of change are not known, it can only be speculated what 
the key elements of the alterations are in terms of behaviour, cognitions, anxiety 
symptoms, trust, sense of control and coping. It would be interesting to explore the 
process involved in these alterations to identify ways to optimize the delivery of 
treatment.  Furthermore, as the prevalence of intra-oral injection fear among girls was 
reported to be significantly higher than among boys, it is reasonable to expect that in 
general, more girls will be referred to or will seek treatment for I-OIP. As girls tend 
to display emotions differently compared to boys, exploring gender differences in 
treatment outcomes would be of further clinical value. 
 60 
 A high level of dental fear was found to be prevalent among children 
and adolescents and was found to be one of the main reasons for avoidance of dental 
care (Paper 2). A consequence may be reduced dental health (115). As CBT is found 
to be efficient in treating children with I-OIP (Paper 3), future research should 
explore the effectiveness of an adjusted CBT version for children with dental phobia. 
 Furthermore, the association between intra-oral injection fear, pain, 
unpleasantness, disgust and fainting should be explored in children and adolescents. 
As these are some of the typical and unique elements of I-OIP (19, 30), the 
prevalence and whether these elements contribute to avoidance of necessary 

















 The novel IOIF-s revealed applicability and satisfying psychometric properties 
in terms of reliability and validity,  to assess the level of fear of intra-oral 
injections among children and adolescents. . 
 High intra-oral injection fear was found to be prevalent among 10-16-year-
olds and associated with avoidance of necessary dental treatment. 
Accordingly, high fear of intra-oral injections should be addressed before 
treatment of dental fear. 
  An association between the diagnose BII phobia and dental phobia was 
implied due to the strong observed overlap between high fear of intra-oral 
injection and high dental fear.  
 CBT performed by specially trained dentist, modified for children and 
adolescents with intra-oral injection phobia is effective and may prevent future 
avoidance of dental treatment. CBT represent a recommended treatment and 
should be offered for patients suffering from intra-oral injection phobia, within 
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Background. A proper assessment tool is needed
to gain more knowledge about fear of intraoral
injections in children.
Aim. The aims of this study were to evaluate the
reliability and validity of the novel Intra-Oral
Injection Fear scale (IOIF-s) and to establish a cut-
off score for a high level of such fear.
Methods. Data were obtained from two samples of
10- to 16-year-olds in Hordaland, Norway. Sample
I, 1460 pupils attending elementary and high
schools, provided questionnaire-based data. The
survey instruments used were IOIF-s, Children’s
Fear Survey Schedule-Dental Subscale (CFSS-DS),
Mutilation Questionnaire for Children (MQ-c) and
Injection phobia Scale for Children (IS-c). Sample
II was 67 patients, diagnosed with intraoral
injection phobia at the Center for Odontophobia,
Oral Health Center of Expertise in Western
Norway-Hordaland, who provided IOIF-s data.
Results. Cronbach’s alpha was 0.95. The IOIF-s
discriminated between subjects with and without
intraoral injection phobia and was associated with
the other survey instruments of similar construct.
Principal component analysis revealed a two-com-
ponent solution, characterized as ‘Contact Fear’
and ‘Distal Fear’. Receiver-operating characteristic
(ROC) curve indicated that a cutoff score of 38
was appropriate.
Conclusion. The IOIF-s showed satisfying psycho-
metric properties in terms of reliability and
validity.
Introduction
Blood-injury-injection (BII) phobia is one of
the five different types of specific phobias
classified in the Diagnostic and Statistical
Manual of Mental Disorders 5 (DSM-5)1.
Individuals with BII-phobia are characterized
by extreme anxiety and avoidance in relation
to seeing blood or injuries, undergoing inva-
sive medical procedures or receiving injec-
tions1. Nausea, aversion and the feeling of
disgust are strongly associated with exposure
to the BII-phobic stimuli2–5. Unique for the
BII-phobia is the high frequency of a vasova-
gal response associated with fainting when
exposed to the phobic stimuli6. Fear and
anxiety provoking situations or those in
which phobic stimuli may be encountered,
are avoided or endured with intense
anxiety1,7.
There are two main subgroups of the BII-
phobia: blood-injury phobia (BIP) and injec-
tion phobia (IP). IP is further divided into
two separate, sometimes overlapping condi-
tions, extra-oral IP (E-OIP) and intraoral IP
(I-OIP)6,8. Extra-oral injections concern a
variety of injections, most often vaccinations,
taking blood samples or intravenous cannula-
tions (e.g., venflons). Intraoral injections are
mainly used for local anesthesia to prevent
procedural pain during dental treatment.
The onset of the BII-phobia has been
reported to be 5.5–10 years of age6,9–11. In
children, poor pain control during dental
treatment, for example due to avoidance of
intraoral injections, may contribute to the
development of dental fear and anxiety12–15.
The early onset of the BII-phobia combined
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with the consequences associated with the
disorder highlights the need for early and cor-
rect identification. With respect to the I-OIP
subtype of IP, detection at an early age is
essential to providing proper treatment and
thus, hopefully, to preventing painful dental
experiences16.
Intraoral IP is a clinical diagnosis which can
only be diagnosed by trained professionals,
usually psychologists or psychiatrists1. They
are capable of distinguishing a high level of
intraoral injection fear from phobia. Never-
theless, tools such as self-reporting question-
naires and psychometric scales are used to
assess the level of fear in clinical dental set-
tings, to estimate its prevalence in a popula-
tion and to register differences between
experimental and control groups8,17. To estab-
lish a proper fear cutoff score on psychomet-
ric scales is essential as it allows us to
distinguish highly fearful individuals from
non-fearful individuals, both in larger popula-
tions and in clinical dental settings. In the
clinical setting, an established cutoff score
may additionally be used to indicate the need
for referral to qualified specialists8,17,18.
Hitherto, there are no articles published
presenting psychometric scales which distin-
guish between extra- and intraoral injection
fear in children. Currently, if at all reported,
fear of intraoral injections is embedded in a
broader fear assessment, or based on single
questions. The widely used Children’s Fear
Survey Schedule-Dental Subscale (CFSS-DS)
assessing dental fear only have one single
item covering fear of intraoral injections19.
Similarly, in the Injection Phobia Scale for
children (IS-c) assessing injection fear in gen-
eral, all but one single item concerning
intraoral injections cover situations regarding
extra-oral injections such as vaccines and
blood samples20, which limits the use in a
dental setting. Also single questions such as
the Visual Analogue Scale (VAS) may be used
for assessing fear of intraoral injections, but
can only cover one aspect of the fear
response17. Although responses to single
questions indicate that fear of intraoral injec-
tions is one of the most common fears related
to dental treatment21,22, it cannot assess the
different aspects and dimensions of the more
complex fear response, which is covered more
broadly in a psychometric scale1,17.
This lack of a scale for measuring intraoral
injection fear in children and adolescents led
a research group at the University of Bergen,
Norway, to develop the Intra-Oral Injection
Fear scale (IOIF-scale) for children and ado-
lescents. In its development, both psycholo-
gists and dentists with expertise in dental
phobia and cognitive behavioral therapy took
part.
The primary aim of this study was to evalu-
ate the reliability and validity of this IOIF-
scale. The secondary aim was to establish a
cutoff score for a high level of intraoral injec-
tion fear.
Materials and methods
Study sample and design
The collected data in this study originated
from two studies administered from the
Center for Odontophobia, Oral Health Cen-
tre of Expertise in Western Norway, Horda-
land, Norway. One study took place at
elementary schools in Hordaland County
(Sample I) and the other (Sample II) at the
Centre for Odontophobia. Data collection
was undertaken from February 2013 to
April 2015.
Sample I (non-clinical sample) comprised
collected questionnaire data from 1460 pupils
(10- to 16-year-olds) attending elementary
schools. The schools were cluster-sampled.
The questionnaires, distributed in classrooms,
were completed within 45 min. A short stan-
dard introduction outlining the anonymity
and purpose of the study was given prior to
completing the questionnaires. The IOIF-scale
included in this paper-and-pencil question-
naire had previously been pilot tested on 154
pupils, 11- to 15-year-olds. In the pilot study,
no problems regarding the understanding of
the content of the IOIF-scale were reported;
hence, no adjustments to the scale were
made.
Additionally, the questionnaire data con-
sisted of Mutilation Questionnaire for Chil-
dren (MQ-c)20, IS-c20, CFSS-DS19,23 and two
single questions regarding avoidance of
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intraoral injections and self-perceived fear of
intraoral injections.
Sample II (clinical sample) consisted of col-
lected data from 67 patients diagnosed with
intraoral injection phobia (10–16 years),
enrolled at the Center for Odontophobia. The
patients had all refused intraoral injections
due to fear prior to enrollment and were
therefore recruited by referral from the Public
Dental Service (PDS). The patients had been
going through a semi-structured diagnostic
interview, carried out by a psychologist, as
part of an ongoing randomized controlled
treatment study. The interview was based on
a modified version of the Anxiety Disorders
Interview Schedule-IV (ADIS-IV)24. In addi-
tion to the interview, the patients had com-
pleted the IOIF-scale. A random subsample of
26 patients also completed the IOIF-scale a
second time with a 5-week interval.
Measuring tools
The IOIF-scale is a 12-item questionnaire in
Norwegian, which assesses fear of intraoral
injections. Each pre-coded response ranged
from 1 to 5 [(1 = not afraid at all, 2 = a little
afraid, 3 = a fair amount, 4 = pretty much
afraid and 5 = very afraid), sum score range:
12–60]. The aim of this scale was to cover dif-
ferent potential fear provoking situations or
objects associated with intraoral injections.
The underlying rationale for obtaining the
measures was to estimate the feeling of fear
evoked in response to exposure to the respec-
tive triggers of fear. The following scales were
all in Norwegian. The Norwegian versions
were based on the Swedish version, as these
two Scandinavian languages are closely
related to each other. For measuring injection
fear, IS-c was applied20. The IS-c, an 18-item
scale, ranged from 0 to 4 [(0 = not afraid at
all, 1 = a little afraid, 2 = a fair amount,
3 = pretty much afraid, 4 = very afraid), sum
score range: 0–72]. The MQ-c was used to
assess blood-injury fear20, which was a 15-
item scale with five response alternatives
[(0 = not afraid at all, 1 = a little afraid, 2 = a
fair amount, 3 = pretty much afraid, 4 = very
afraid), sum score range: 0–60]. Also the
CFSS-DS, a scale consisting of 15-items
measuring dental fear in children was
applied19,23. The five response options were
graded from 1 to 5 [(1 = not afraid at all,
2 = a little afraid, 3 = a fair amount,
4 = pretty much afraid, 5 = very afraid), sum
score range: 5–75]. The respondents of the
questionnaires were further asked to estimate
the probability of proceeding with dental
treatment when an intraoral injection was
needed. The options were ‘definitely’, ‘proba-
bly’, ‘probably not’ and ‘certainly not’. Avoi-
ders were defined as those responding
‘certainly not’, and non-avoiders were
defined as those responding ‘definitely’. Fur-
thermore, self-perceived fear of intraoral
injections was evaluated using VAS (0 = no
fear at all; 10 = terrified).
Statistical analysis
Internal consistency reliability of the IOIF-
scale was assessed by Cronbach’s alpha, alpha
if item deleted, inter-item correlation
coefficients and the corrected item–total cor-
relation. Test–retest was assessed by the intra-
class correlation coefficient.
To assess concurrent validity, the IOIF-scale
sum scores data from Sample I and Sample II
were compared by an independent sample t-
test. Leven’s test for equality of variances was
conducted for the t-tests. When the assump-
tion of equal variances was violated, t-statis-
tics not assuming homogeneity of variances
were computed. Construct validity, both con-
vergent and divergent, was also evaluated in
the following analyses (Sample I); the IOIF-
scale scores of the non-avoiders and the avoi-
ders were compared, using an independent
sample t-test. Spearman’s correlations were
also calculated between the sum score of
IOIF-scale and the single question rating self-
perceived fear of intraoral injections. Further-
more, Spearman’s correlations between the
IOIF-scale and the MQ-c, IS-c and CFSS-DS
sum scores were performed.
Principal component analysis (PCA) with
oblimin rotation was conducted to identify
the underlying structure (Sample I). Kaiser–
Meyer–Olkin (KMO) measure of sampling
adequacy) and Bartlett’s test of sphericity
were checked before interpreting the rotated
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component loadings. Factorability of the cor-
relation matrix was further assured by check-
ing for at least some correlations of r = 0.3 or
greater. Component loadings above 0.4 were
considered as substantial loading on a particu-
lar subset of items. The number of compo-
nents to be retained was guided by three
decision rules: (1) by Kaiser’s criterion (eigen-
values above 1), (2) by inspection of the
screeplot (components above the change in
the shape of the plot were retained) and (3)
by use of parallel analysis25. In the parallel
analysis, the sizes of the eigenvalues obtained
from PCA were compared with those
obtained from a randomly generated data set
of the same size. Components with eigenval-
ues exceeding the values obtained from the
corresponding random data set were consid-
ered separate components.
The receiver-operating characteristic (ROC)
curve was used to determine the most dis-
criminant IOIF-scale cutoff score, in order to
separate those with I-OIP from all others,
with the best balance between sensitivity and
specificity17. The ROC was illustrated graphi-
cally, and the area under the curve (AUC)
was calculated both for the continuous IOIF-
scale and for the IOIF-scale dichotomized by
the cutoff value chosen, against the patients
diagnosed with I-OIP (Sample II) as a refer-
ence standard.
Sum scores on the scales were calculated
using the mean of the items multiplied with
the number of items. Mean values were cal-
culated if 20% or fewer of the items had
missing information for each individual. The
sum score for individuals with missing infor-
mation on 20% or fewer was hence imputed
and replaced the missing values, using the
mean of the other items. Due to item non-
response, N differed slightly between analy-
ses. Data were analyzed using SPSS version
22.0 (IBM, Armonk, NY, USA). Parallel
analysis was conducted using the software
developed by Watkins25.
Ethical approval
Approval by the Regional Committees for
Medical and Health Research Ethics in Nor-
way, 2010/63-3, was obtained. Permission to
conduct the questionnaire study at schools
was obtained from the educational authorities
and school administrations in each municipal-
ity. Informed passive consent was obtained
both from the pupils and their guardians. In
the study in which patients were included,
written informed consent was obtained from
patients and their guardians.
Results
In the 31 schools which accepted the invita-
tion to participate in the study (Sample I),
only 19 pupils declined to participate, yielding
a response rate of 98.7%. The mean age of
the participants (N = 1441) was 12.7 years
(SD = 1.9), and 50.9% were girls. Age distri-
bution is shown in Table 1. In Sample II, the
mean age of the participants (N = 67) was
12.2 years (SD = 2.0), and 58.2% were girls.
Internal consistency reliability and reproducibility
The internal consistency reliability of the
items in the IOIF-scale (Sample I) yielded a
Cronbach’s alpha value of 0.95. As shown in
Table 2, the corrected item–total correlation
coefficient ranged from 0.59 (Item 6, hear
somebody talk about having an intraoral injec-
tion) to 0.88 (Item 8, sitting in a dental chair,
waiting for the intraoral injection). The correla-
tion matrix showed no negative correlations.
The interitem correlations ranged from 0.38
(item 6 and item 10; hear somebody talk about
having an intraoral injection and the anesthesia
not working) to 0.86 (item 8 and item 1; sitting
in a dental chair, waiting for the intraoral injec-
tion and when the dentist says you need an
intraoral injection) (Table 3).
Table 1. Distribution of participants according to sex and
age (Sample I).
Age (year) Girls Boys Sex not reported Total
10 89 84 – 173
11 170 147 4 321
12 112 134 4 250
13 107 92 – 199
14 85 75 1 161
15 88 72 2 162
16 76 97 2 175
Total 727 701 13 1441
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In Sample II, analysis performed on the 26
duplicate recordings on the IOIF-scale gave
an intra class correlation of 0.79 (95% CI:
0.53–0.90).
Validity
The mean sum score of the IOIF-scale dis-
criminated significantly between participants
in Sample I (mean = 23.67, SD = 11.23)
and Sample II (mean = 40.22, SD = 8.9),
P < 0.001). The IOIF-scale total score discrim-
inated significantly between non-avoiders of
intraoral injections and the avoiders of intrao-
ral injections (respectively, mean = 17.93,
SD = 7.68, vs mean = 38.76, SD = 13.21,
P < 0.001) with a mean difference of 20.83
[(95% CI: 24.55–17.11), g2 = 0.15]. There
was a significant correlation between the sum
score for the IOIF-scale and the participants’
single question rating self-perceived fear of
intraoral injections, q = 0.78, P < 0.001.
Additionally, a significant correlation
between the sum scores of the IOIF-scale and
IS-c was found (q = 0.83, P < 0.001), and also
between the sum scores of the IOIF-scale and
MQ-c (q = 0.65, P < 0.001). The correlation
between the IOIF-scale and IS-c showed sig-
nificantly higher values than the correlation
between the IOIF-scale and MQ-c (Z = 10.94,
P < 0.001). There was also a significant corre-
lation between the IOIF-scale and the mea-
sure of CFSS-DS (q = 0.83, P < 0.001).
As for the suitability for PCA, the Bartlett’s
Test of Sphericity showed high significance
(P < 0.001), whereas the KMO measure of
sampling adequacy showed a value of 0.95,
supporting the factorability of the matrix.
Inspection of the correlation matrix also
revealed the presence of several coefficients
above 0.3.
Principal component analysis and oblimin
rotation revealed the presence of two compo-
nents with eigenvalues exceeding 1, values
showing 7.7 and 1.02 (Table 4). On the basis
of 0.4 as salient loading, inspection of the pat-
tern matrix revealed that there were no items
with loadings on multiple components, and
both components had items with salient load-
ings. The two components accounted for
72.7% of the total scale variance. The first
component explained 64.2% of the variance,
whereas the second component accounted for
8.5%. Pearson’s correlation between the two
components was r = 0.65. An inspection of
the screeplot indicated a break after the sec-
ond component. The parallel analysis showed
one component with eigenvalue exceeding
the corresponding criterion value for a ran-
domly generated data matrix of the same size
(12 variables 9 1441 respondents). The first
random eigenvalue generated by the parallel
analysis was 1.15. The second random eigen-
value was 1.11 and exceeded the second
Table 2. Intra-Oral Injection Fear scale (IOIF-s): mean (SD),
corrected item with total correlation, alpha if item deleted
(Sample I).
IOIF-s item







IOIF-s 1: when the dentist
tells you that you will
need an anaesthetic
injection
2.25 (1.25) 0.86 0.94
IOIF-s 2: when you feel
the sting from the
syringe
2.39 (1.32) 0.85 0.94
IOIF-s 3: when the dentist
applies anesthetic
ointment to your gums
1.72 (1.06) 0.77 0.94
IOIF-s 4: for the
anesthetic liquid itself
1.76 (1.08) 0.75 0.94
IOIF-s 5: when you see a
picture of a person
being anesthetized at
the dentist
1.44 (0.85) 0.68 0.95
IOIF-s 6: when someone
tells you that they have
had an anesthetic
injection at the dentist
1.32 (0.74) 0.59 0.95
IOIF-s 7: that the sting
from the syringe will be
painful
2.40 (1.31) 0.83 0.94
IOIF-s 8: when you are
sitting in the dentist’s
chair preparing to have
an anesthetic injection
2.38 (1.37) 0.88 0.94




1.77 (1.09) 0.74 0.94
IOIF-s 10: that the
anesthetic will not work
2.31 (1.37) 0.69 0.95
IOIF-s 11: when you see
the needle of a syringe
2.34 (1.41) 0.82 0.94
IOIF-s 12: when you see a
picture of a dentist’s
syringe
1.56 (1.04) 0.66 0.95
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eigenvalue generated by the PCA slightly,
being 1.02.
Receiver-operating characteristic curve
Identification of I-OIP by the continuous scale
showed an AUC of 0.87 (95% CI: 0.84; 0.90
P < 0.001). The ROC curve showed that by
dichotomizing the IOIF-scale at a cutoff score
of 38, I-OIP was detected with a sensitivity of
0.61 and a specificity of 0.85, AUC = 0.73
(95% CI: 0.66; 0.80 P < 0.001). The cutoff
score of 38 was set, as a lower cutoff score
increased the sensitivity but decreased the
specificity (Fig. 1).
Discussion
To our knowledge, the IOIF-scale presented
in this article is the first scale developed to
assess fear of intraoral injections in children
and adolescents. Overall, the psychometric
properties of the scale demonstrated satisfying
reliability and validity and provided further
support for wider applicability of the IOIF-
scale within this age group in the county of
Hordaland, Norway.
As for assessing dental fear and anxiety in
children, several scales have previously been
developed26,27. It is known from the literature
that intraoral injections constitute one of the
most anxiety provoking stimuli for children
and adolescents related to the dental set-
ting15. The need for the development of an
appropriate psychometric instrument assess-
ing this specific fear in children should there-
fore be obvious, and the aspect of identifying
the anxiety provoking stimuli in the dental
clinic due to such an instrument would be
highly valued. A scale which could assess the
level of fear would also be of great impor-
tance for research purposes, enabling the
prevalence of fear of intraoral injections to be
estimated and the need for resources in terms
of treatment to be assessed.
A strength of the study was the relatively
high amount of collected data behind the
study results and the high response rate
among the pupils in Sample I. Nevertheless,
one should bear in mind that those few who
did not participate might have differed from
the rest of the sample, as high fear may cause
Table 3. Inter-item correlation matrix for Intra-Oral Injection Fear scale (IOIF-s) scores (Sample I).
1 2 3 4 5 6 7 8 9 10 11 12
IOIF 1 1.00
IOIF 2 0.85 1.00
IOIF 3 0.67 0.68 1.00
IOIF 4 0.64 0.65 0.70 1.00
IOIF 5 0.56 0.54 0.61 0.60 1.00
IOIF 6 0.50 0.44 0.49 0.48 0.63 1.00
IOIF 7 0.79 0.79 0.61 0.61 0.54 0.46 1.00
IOIF 8 0.86 0.84 0.69 0.64 0.56 0.50 0.81 1.00
IOIF 9 0.65 0.65 0.65 0.68 0.56 0.50 0.61 0.66 1.00
IOIF 10 0.60 0.62 0.56 0.55 0.43 0.38 0.64 0.63 0.56 1.00
IOIF 11 0.75 0.76 0.62 0.58 0.54 0.45 0.76 0.78 0.60 0.63 1.00
IOIF 12 0.53 0.53 0.54 0.50 0.66 0.57 0.52 0.56 0.47 0.45 0.63 1.00
Table 4. Oblimin rotated pattern matrix and communalities
for the Intra-Oral Injection Fear scale (IOIF-s). Rotation
converged in five iterations (Sample I).
Pattern coefficients
Communalities
Comp 1 Comp 2
Eigenvalue 7.7 1.02
% Total variance 64.2 8.5
Item
IOIF item 2 0.961 0.072 0.839
IOIF item 8 0.932 0.013 0.852
IOIF item 1 0.916 0.014 0.823
IOIF item 7 0.911 0.039 0.785
IOIF item 11 0.823 0.058 0.743
IOIF item 10 0.818 0.080 0.590
IOIF item 9 0.614 0.233 0.617
IOIF item 3 0.558 0.324 0.651
IOIF item 4 0.542 0.329 0.634
IOIF item 6 0.071 0.895 0.724
IOIF item 5 0.055 0.846 0.778
IOIF item 12 0.111 0.748 0.680
Major loadings on each item are bolded.
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avoidance or reluctance in answering ques-
tions about intraoral injections1.
The reliability of the scale was demonstrated
by the fact that the internal consistency of the
IOIF-s was shown to be excellent, indicating
homogeneity of the scale17. This was further
supported by examining the impact of remov-
ing each item from the scale, revealing no
items with a value higher than the final alpha
value obtained, which confirmed the use of
the 12 items comprising the scale. The interi-
tem correlations were all positive, indicating
that the items of the scale were correlated
with each other. Nonetheless, the correlations
were not considered high enough for any item
to be excessive17.
The test–retest reliability obtained indicates
that the sum score of the IOIF-scale generated
at a single assessment could be representative
for the level of intraoral injection fear at
another point in time. The scale was completed
at the Center for Odontophobia at both time
points. At the first assessment, the patients
underwent semistructured diagnostic interview
by the psychologist, which may have influ-
enced their ratings at the following session. It
could therefore be expected that the Intra Class
Correlation obtained might be conservative.
The IOIF-scale demonstrated concurrent
validity in discriminating strongly between
the respondents with and without a known
diagnosis of intraoral injection phobia. This
emphasizes the ability of the IOIF-scale to dif-
ferentiate highly fearful children from a larger
reference population, an essential feature for
usefulness not only as a screening tool, but
also in a clinical context17,28.
Construct validity was shown in that the
IOIF-scale discriminated strongly in the
expected direction between the respondents
characterized as avoiders and those character-
ized as non-avoiders of intraoral injections.
This could be anticipated as avoidance is asso-
ciated with the specific phobia1, and was also
supported by the large effect size, indicating
that the scale was able to detect differences
between the groups. The strong correlation
between the IOIF-scale sum score and the
patients’ self-perceived fear of intraoral injec-
tions based on ratings on a single question
added support to the convergent validity.
The IOIF-scale further illustrated construct
validity, as the test scores were associated
with the dental fear scale (CFSS-DS). Addi-
tionally, it showed stronger associations with
the injection fear scale (IS-c) than the blood-
injury fear scale (MQ-c), both currently used
assessing BII-fear related to dental settings.
This difference in strength of correlations
with IS-c and MQ-c might also be seen as
support for the divergent validity for the IOIF
as the theoretical fundament of fear of intrao-
ral injections is closer to fear of injections
than the construct measured by MQ-c6.
Fig. 1. Receiver operating characteristics
curve for Intra-Oral Injection Fear scale
(IOIF-s) dichotomized by a cutoff score of
38, and for the continous IOIF-s sum
scores.
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Although the correlation with IS-c, MQ-c and
CFSS-DS was considered high, it was not
overly high, suggesting that the IOIF-scale
covered components of this trait not tapped
by the existing scales17.
The PCA revealed that the Kaiser’s crite-
rion, based on the eigenvalues extracted, and
the screeplot, both were supportive of a two-
component structure of the IOIF-scale. The
parallel analysis, on the other hand, indicated
that a one component structure also had to
be taken into consideration; however, the
indistinct demarcations of the components
revealed by the PCA, combined with the the-
oretical coherence, favor a two-component
structure classified as ‘Contact Fear’ and ‘Dis-
tal Fear’. The ‘Contact Fear’ component,
which accounted for the strongest part of the
intraoral injection fear, included nine of the
items which were related to the respondents’
fear of actual contact with the intraoral injec-
tion procedure. The component classified as
‘Distal Fear’ was found to explain part of the
construct, but accounted for a far less promi-
nent part of the variance. This component
included three of the items, all relating to
indirectly or remotely contact with intraoral
injections. The PCA thus indicated that the
IOIF-scale measured the relevant construct
explained by the components ‘Contact Fear’
and ‘Distal Fear’ and that the component
structure was theoretically adequate, support-
ing the construct validity of the IOIF-scale.
The two components were comparable to
the two factors extracted by factor analysis of
the IS-c, and the two components extracted
by the PCA of the Injection Phobia Scale-
Anxiety (IPS-Anx) (assessing injection fear in
adults), where the labeling ‘Contact Fear’ and
‘Distal Fear’ also were suggested20,28. There
were no items in the IOIF-scale with loadings
on more than one factor. In comparison, the
IS-c has one item loading on both factors,
based on the criterion of 0.40 as salient load-
ing, whereas the IPS-Anx equivalently has
two items loading on both components28.
One of the main properties of a scale is
its ability to interpret the scores, allowing
both appropriate referrals, and statistical com-
parison of tests. The appropriate cutoff value
for the IOIF-scale set to separate persons with
high intraoral injection fear from persons
with low and moderate intraoral injection
fear was 38 (sum score 12–60). This cutoff
value demonstrated moderate discriminative
properties18. By choosing a lower cutoff
value, the sensitivity would increase. From a
clinical and research perspective, it can be
argued that specificity in this case is more
important than sensitivity. Fear, anxiety and
phobia in children emanate from a contin-
uum1, and therefore, it could be regarded as
more valuable in this case, ensuring that
those who are classified as not having a high
level of fear of intraoral injections are cor-
rectly identified. As the diagnosis intraoral
injection phobia cannot be determined solely
by a scale, but must be set by a psychologist,
the cutoff value set was reasonable for the
target population, separating clinical from
subclinical respondents. Still, a limit to the
cutoff value set is that the sensitivity obtained
was relatively low in favor of gaining higher
specificity. Consequently, the cutoff value has
to be interpreted with caution.
The scale was developed for children as a
self-report measure, and not completed as a
proxy measure provided by guardians. This
strengthened the reliability and validity of the
scale, as studies show moderate agreement
between child and parental ratings on self-
reports29. Content validity was supported by
the fact that children participated in the pilot
study, securing that the language and termi-
nology were comprehensible for the target
group.
As the onset of BII-phobia is varying from
5.5 to 10 years of age6,9–11, this scale was
designed to capture children from the age of
10–16 years. The lower limit was both to
ensure that the phobia in most of the chil-
dren was fully developed, but also to secure
that the children were able to complete the
questionnaire by themselves. Below the age
of 10, the wording of the scale would proba-
bly have to be somewhat modified, and per-
haps assisted by symbols, due to the
children’s cognitive maturation30. Addition-
ally, a scale completed as a proxy measure
would have to be considered.
A limitation of the scale was that it did not
assess physical reactions, thoughts or
8 K. G. Berge et al.
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behavior, which also are elements influencing
fear and anxiety of intraoral injections27. Nor
did the scale assess whether the anxiety influ-
enced daily living, which is required to meet
the criteria for diagnosis of a specific phobia.
On the other hand, this allowed the scale to
be brief and let the children complete the
scale by themselves, making it relevant and
easy to use for the dental team.
Cross-validation in different cultural set-
tings is needed for further generalization of
the validity of the scale. In future research,
further clinical evaluation of the scale should
be assessed, as it is important to demonstrate
that the scale is sensitive to change during
treatment of intraoral injection phobia. Age
and sex differences should be described and
further explored.
In conclusion, the IOIF-scale showed satis-
fying psychometric properties in terms of reli-
ability and validity in children and
adolescents in Hordaland. The cutoff score of
38 on the IOIF-scale was found to be appro-
priate for detecting a high level of intraoral
injection fear in this sample. The IOIF-scale
should therefore be seen upon as useful in
the dental clinic for the evaluation of the
child’s intraoral injection fear and as an
appropriate research tool for prevalence stud-
ies of high intraoral injection fear in children
and adolescents. It represents a useful supple-
ment to the psychologist’s clinical judgement.
Why this paper is important to paediatric dentists
• As intraoral injection is known to be one of the most
anxiety provoking stimuli for children in a dental set-
ting, the development of an appropriate psychometric
instrument assessing this specific fear should be of
great value for the pediatric dentist.
• Identification of high fear of intraoral injections at an
early age is important for the provision of appropriate
treatment for the patient, to prevent painful dental
experiences and to allow the prevalence of fear of
intraoral injections in a population to be assessed.
• An established cutoff score on the IOIF-s is essential
to distinguish highly fearful individuals from non-fear-
ful individuals, both in a larger population and in a
clinical dental setting. Additionally, in a clinical dental
setting, the cutoff score on the IOIF-s may be used to
indicate the need for further referral to qualified
specialists.
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Abstract: 
The present study aimed to (i) estimate the prevalence of self-reported high fear of intra-oral 
injections, high blood-injury fear and injection fear, (ii) explore the overlap between high fear of intra-
oral injections and high fear of dental treatment, and (iii) evaluate the possible consequence of high 
fear of intra-oral injections in terms of avoidance of dental care. The sample included 1441 10-16-
year-olds attending elementary schools in a county of Norway. Data were collected by use of 
questionnaires completed in classrooms. The survey instruments used were Intra-Oral Injection Fear-
scale, Children's Fear Survey Schedule-Dental Subscale, Injection Phobia scale for children, and 
Mutilation Questionnaire for children. In total, 13.9% of the children reported high intra-oral injection 
fear. A strong association was found between fear of intra-oral injections and dental fear. When an 
intra-oral injection was needed, 10.6% would avoid dental treatment. In multiple regression analysis, 
high intra-oral injection fear was found to be associated with avoidance of dental treatment (OR=6.52; 
95% CI 3.99-10.67). It was concluded that high fear of intra-oral injections was prevalent, and might 
lead to avoidance of necessary dental treatment. Hence, intra-oral injection fear should be addressed 
before treatment of dental fear.       
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Blood-Injury-Injection (BII) phobia constitutes one of five different types of specific phobias, and 
consists of two subgroups, blood-injury phobia (BIP) and injection phobia (IP) (1, 2). BII phobia has 
usually its onset prior to 10 years of age (3-5), and is in contrast to other phobias associated with a 
vaso-vagal response (6, 7). Experiences of both high fear and fainting according to BII stimuli, are 
reported to be linked to avoidance or denial of necessary dental and medical treatment (8-10). IP can 
be further divided into two separate conditions; extra-oral and intra-oral injection phobia, respectively 
(11, 12).   
 Intra-oral injections have been shown to be among the most fear-provoking stimuli in the 
dental setting (13-16), but the prevalence figures for this fear are inconsistent. A study among Dutch 
children aged 4-11 years showed that high fear of needles related to dental treatment was higher 
among the younger children than the older (17). The reported prevalence was 11% among 10-11-year-
olds, but 19% among 4-6-year-olds. In a sample of Norwegian 18-year-old adolescents, 17% had 
experienced high fear during their last intra-oral injection (18). The prevalence was higher among girls 
than boys, and higher for intra-oral injections than extra-oral injections. Also, 3.3% reported that they 
would avoid dental treatment if they knew that an intra-oral injection was needed. Likewise, 4.6% of 
students and staff at the University of Washington were found to have avoided intra-oral injections 
due to fear (10). To our knowledge, there are no published studies about avoidance of treatment due to 
intra-oral injection fear among children.  
 Although intra-oral injection phobia and dental phobia are considered separate conditions 
according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) (1), a substantial 
overlap has been documented between dental fear and BII fear (13, 19, 20), and between dental fear 
and the BII subgroup intra-oral injection fear (11). However, these findings of overlap are only 
reported among 18-year-olds and adults, whereas similar assessment among children is lacking in the 
literature. Patients avoiding dental injections due to high fear or phobia of intra-oral injections are 
more likely to experience painful dental procedures. Painful dental experiences, anticipated fear of 
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such pain and negative dental experiences are documented to be predictors for developing dental fear 
and anxiety (21-23). All this corroborates that the prevention of negative experiences connected with 
intra-oral injections is of vital importance. Early assessment of high intra-oral injection fear is 
therefore essential in order to offer the affected patients appropriate treatment, such as cognitive 
behavioural therapy (24-26) and/or applied tension (27). The reasons for a lack of knowledge of intra-
oral injection fear and variations in prevalence estimates might be that adequate assessment methods 
have been lacking and that different criteria have been used for assessing the fear. The prevalence 
estimates for intra-oral injection fear which have hitherto been published are based on single questions 
(17, 18). The newly published Intra-Oral Injection Fear-scale (IOIF-s) (28) should in this respect 
represent an improvement because it was found to be a reliable and valid assessment tool.   
 The aims of the study were (i) to estimate the prevalence of self-perceived high fear of intra-
oral injections, blood-injury fear and injection fear among 10-16 year-olds, (ii) to explore the overlap 
between high fear of intra-oral injections and high fear of dental treatment, and (iii) to evaluate the 
possible consequence of high fear of intra-oral injections in terms of avoidance of dental care.  
Material and methods   
The study was approved by the Regional Committees for Medical and Health Research Ethics in 
Norway (REC number 2010/63-3). Permission to conduct the study was obtained from the educational 
authorities and school administrations in each municipality.  
 This cross sectional questionnaire study included 10-16-year-old pupils, attending public 
elementary schools in Hordaland County, Norway. The data collection was carried out between 
January 2014 and March 2015. Since classical conditioning is one of the main etiological factors in 
BII phobia (9), sampling based on public dental clinics was conducted in order to minimize the effect 
of single dentists treating all pupils in the area. Public dental clinics in Hordaland County ranged from 
large to small (n=46). The schools belonging to the catchment areas of the largest public dental clinic, 
according to the list, were first invited to participate in the study. Subsequently, the schools in the 
catchment areas of the consecutive public dental clinics of the list were invited. The selection of 
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schools stopped when the required sample size was reached. According to Statistics Norway (29) , the 
total population of 10-16-year-olds in Hordaland County was approximately 44,000 children. The 
sample size calculation was based on results from a pilot study which found a prevalence of high intra-
oral injection fear of 6%. This value for prevalence, and an absolute precision of 2% with a 95% 
confidence interval, gave a sample size of 550 pupils. To ensure detecting differences in prevalence 
between age groups (10-12 year-olds vs 13-16 year-olds) and sex, the sample size needed was 1100.  
The dichotomization of age groups was chosen in order to detect age effects due to cognitive 
maturation and further development of executive functions (30). Additionally, the dichotomization 
refers to pupils respectively attending primary and secondary school. Assuming an anticipated drop-
out of 25%, the final sample size was set to 1400.  
 An information sheet about the study was distributed to parents/guardians in advance by the 
teacher to the pupils, and also sent to the guardians by e-mail. It outlined the purpose and anonymity 
of the study and that participation was optional, and it underlined the opportunity to opt out. Contact 
information for the first author was provided. The information sheet was in Norwegian, and the 
reading level basic and easy readable, because some parents/guardians were possibly not fluent in 
Norwegian (the immigrant population of Hordaland County was estimated to be approximately 10% 
(31)). Informed passive consent was obtained from both the children and their guardians. Passive 
consent was approved because the questionnaire was considered of such a character that this limitation 
was found acceptable. On the day of the investigation, the pupils also received a short standard 
introduction from the first author. The purpose of the study and the content of the questionnaire were 
shortly explained. The voluntariness and anonymity was outlined, and the pupils were told that they 
could disrupt the completion at any time. Further, the pupils were told to answer the questionnaire by 
themselves; however, the first author could answer questions about the content during the completion. 
Pupils already having extra assistance at school (e.g. due to learning disabilities or language 
difficulties) were allowed to have extra assistance also during the completion. Completion of the 
questionnaires was performed in a classroom (45 min), supervised by the first author, and with a 
teacher present. A copy of the questionnaire may be obtained from the corresponding author. 
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 The first section of the questionnaire consisted of demographic items such as year of birth and 
sex.  The second section included single questions concerning intra-oral injections. A) Time since last 
intra-oral injection: (< 1 yr ago, ≥1 yr ago, never received or can’t remember having received one). B) 
Avoidance of intra-oral injections: The pupils were asked to estimate how sure they were of being able 
to cope with dental treatment, knowing that an intra-oral injection was required ("definitely", 
"probably", "probably not", "certainly not"). The third section included psychometric instruments 
assessing BII fears.  A) Intra Oral Injection Fear Scale (IOIF-s), a 12-item self-report instrument 
validated in 10-16-year-olds, was applied (28). Each response was scored from 1 to 5 (1 = not afraid at 
all, 5 = very afraid) with a sum score range from 12 to 60. A cut-off score of 38 was used to indicate 
high fear of intra-oral injections (28). B) Fear of Dental treatment: By use of Children’s Fear Survey 
Schedule–Dental subscale (CFSS-DS) which consisted of 15-items measuring dental fear in children 
(32, 33). The five response options were graded from 1 (not afraid at all) to 5 (very afraid), with a sum 
score range from 15 to75. The scale is validated in 4-15-year-olds and a cut-off score of 38 was used 
to indicate high dental fear (33-36) . C) Fear of injections: By use of  Injection Phobia Scale for 
children (IS-c) , an 18-item questionnaire assessing fear of injections validated in 8-17-year-olds, each 
response option ranged from 0 to 4 (0 = not afraid at all, 4 = very afraid) (37). Sum score varied from 
0 to 72. There is no validated cut-off score. D) Blood-injury (BI) fear: Mutilation Questionnaire for 
children (MQ-c), validated in 8-17-year-olds, was a 15-item instrument with five response alternatives 
in each item ranging from 0 to 4 (0 = not afraid at all, 4 = very afraid) (37). Sum score varied from 0 to 
60. There is no validated cut-off score. The last three self-report instruments were in Norwegian, based 
on the validated Swedish versions, as these two Scandinavian languages are closely related.  
 Variables were constructed for logistic regression analysis. The dependent variable was 
“Avoiders”/”Non-avoiders” where Avoiders (1), were those responding "certainly not" or "probably 
not", while Non-avoiders (0) were those responding "definitely" or "probably" when asked how sure 
they were of being able to cope with dental treatment, knowing that an intra-oral injection was 
required. Independent variables also underwent dichotomization. The dichotomization of the variable 
“High/Not high fear of intra-oral injections", was based on the sum score achieved on the IOIF-s, 
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(High fear (> sum score 38 (1), Low fear (≤sum score 38 (0)). The variable "High/Not high dental 
fear", was similarly based on the sum score achieved on the CFSS-DS (High dental fear (>sum score 
38 (1), Low dental fear (≤sum score 38 (0)). The variable "Sex" was "Girls" (1) and "Boys"(0), and the 
variable "Age" was divided into "Youngest" (10-12 yr (0)) and "Oldest" (13-16 yr (1)). The variable 
"Experience with intra-oral injections" was dichotomized "Yes (1) /No" (0). Participants who 
responded having received intra-oral injections " <1 yr ago" or " ≥1 yr ago" were coded as "Yes". The 
participants responding "never received or can’t remember having received intra-oral injections" were 
coded as "No".   
 Statistical analyses were performed using SPSS, version 22.0 (IBM, Armonk, NY, USA). 
Group differences were analyzed with one-way analysis of variance. Leven’s test for equality of 
variances was conducted for the analysis of variances. When the assumption of equal variances was 
violated, the Welch test, not assuming homogeneity of variances was conducted. Effect size (eta-
squared) was calculated for differences in mean sum scores between groups, and the results based on 
the following guidelines: 0.01=small effect, 0.06= medium effect, 0.14=large effect (38).  Chi-square 
tests with Yates Continuity Correction were employed to assess associations and differences between 
groups of participants with a high level of fear of intra-oral injections, and those with a high level of 
dental fear.  
 Logistic regression models were used to investigate associations between independent 
variables and the dependent variable. Both bivariate and multiple (standard) analyses were carried out, 
and provided Odds Ratios (ORs) with 95% Confidence Intervals (CIs). Multicollinearity between the 
independent variables was assessed by Pearson's correlation coefficient. 
 Sum scores on the scales were calculated using the mean of the items multiplied by the 
number of items. Mean values were calculated if 20% or fewer of the items had missing information 
for each individual. The sum score for individuals with missing information on 20% or fewer was 




Owing to a strike at a national level among teachers during the period of the study and a busy schedule 
for other teachers, 61 schools of those invited refused to participate in the study. New schools were 
invited until the sample size was reached. In total, 31 schools participated in the study (33.7% of the 
invited schools). In total, 1460 10-16-year-olds were invited to participate in the study. Since only a 
few pupils (n=19) for unknown reasons did not participate in the study, the final sample consisted of 
1441 participants, yielding a response rate of 98.7%. Of the participants reporting sex (n=1428), 
50.9% were girls (Table 1). The majority of the children (59.4%) responded that they could remember 
having had an intra-oral injection, with 31.1% having had one in the past year.    
 The mean scores for the scales IOIF-s, CFSS-DS, MQ-c and IS-c are shown in Table 2. The 
mean scores in all four scales were significantly higher in girls (p<0.001). The mean IOIF-s sum score 
differed by age, showing significantly higher values for the youngest age group than the oldest 
(M=24.7, SD= 11.2 vs M= 22.5, SD=11.1, p<0.001, F (1, 1416) = 13.6, eta squared = 0.01).  
 A Chi-square test indicated a significant association between those with a score above cut-off 
of the IOIF-s and sex, χ2 (1,n=196) = 62.03; p<0.001. In total, 13.9% (21.1% of girls, 6.4% of boys) 
scored above the cut-off for the IOIF-s. Furthermore, there was a significant association between those 
with a score above cut-off of the CFSS-DS and sex, χ2 (1,n=166)=39.38; p<0.001. In total, 11.7% 
(17.1% of girls and 6.2% of boys) scored above the cut-off on the CFSS-DS.    
   A significant association was found between fear of intra-oral injections and dental 
fear, χ2 = 440.8 (1,n=1409)=440.8, p<0.001. Among all of the children, 7.9% (n=112) had both high 
fear of intra-oral injections and high dental fear. Of the pupils reporting high fear of intra-oral 
injections, 57.7% (n=112/194) also reported high dental fear, while 66.3% (n=112/169) of those 
reporting high dental fear also reported high fear of intra-oral injections. 
 As shown in Table 3, pupils with a high IOIF-s sum score had significantly higher mean sum 
scores on the CFSS-DS, MQ-c and IS-c scales than pupils with low IOIF-s sum score (p<0.001). 
Among pupils belonging to the high IOIF-s group, there were no significant sex differences.  
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  The IOIF-s mean sum score was significantly lower among those who had previously 
experienced intra-oral injections, than those with no prior experience of intra-oral injections or no 
recollection of such (M=22.2, SD=10.6 vs M=25.9, SD=11.9, p<0.001, F (1,1115)=37.1, eta 
squared=0.03). 
 Cross-tabulation showed that a total of 10.6% of the children, 12.3% of the girls and 8.8% of 
boys, were characterized as avoiders. In the group of avoiders, 59.1 % were girls. The mean and total 
sum scores (IOIF-s, CFSS-DS, MQ-c and IS-c) of the Avoiders, and the Non-avoiders are compared in 
Table 4, and show significantly higher sum scores on all four scales among Avoiders. The effect size 
was largest with the IOIF-s (eta squared =0.188). 
 Table 5 presents associations between the independent variables ("High/Not high fear of intra-
oral injections", "High/Not high dental fear", "Girls"/"Boys", "Oldest"/"Youngest", "Experience/No 
experience with intra-oral injections") and the dependent variable ("Avoiders/Non-avoiders"). The 
Table illustrates that all of the independent variables were significantly associated with Avoiders. The 
peak OR values were found for IOIF-s (OR=12.7) and CFSS-DS (OR=10.5). 
 Multiple logistic regression analysis with the same dependent variable ("Avoiders/Non- 
avoiders") is shown in Table 6. IOIF-s, CFSS-DS and previous experience with intra-oral injections 
were significantly associated with the dependent variable. 
Discussion 
In the present study, we found that high BII fear, and the subtype high fear of intra-oral injections, was 
prevalent among 10-16-year-olds. Furthermore, a strong association between high intra-oral injection 
fear and high dental fear was indicated within the same age group. High fear of intra-oral injections, 
high dental fear and no previous experience with intra-oral injections were found to be predictors of 
avoidance.  
 The study is based on a large sample of pupils from Hordaland County, Norway. The teacher 
strike leading many of the schools to decline participation was at a national level, afflicting public 
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elementary schools regardless of area and demographic characteristics. Thus, the impact on the 
outcome measures of the study is probably limited. The response rate among the pupils was found to 
be excellent. Nevertheless, the sample was limited to only one Norwegian county and was not 
representative of all Norwegian pupils within this age range. The structure of the public dental service 
(PDS) and the public school system in the county is based on national guidelines. The PDS in Norway 
is free of charge for all children within this age range, and approximately 97.5% (29) of all children 
attend public elementary schools. It is therefore reasonable to believe that the findings reflect the 
situation for the chosen age group in Norway.   
 The sex differences on all four scales were shown to be statistically significant, which is in 
line with previous studies (11, 34). Whether this is a result of girls expressing their fears more freely 
on self-report scales cannot be determined by this study, but should be kept in mind when interpreting 
the results (39). Among the high IOIF-group, there was no significant sex difference in any of the 
scales. Also, there was a statistically significant age gradient in fear of intra-oral injections. However, 
the effect size statistics showed that the magnitude of the differences between the groups was small, 
indicating no strong age influence. A larger sample size allowing us to look at differences between 
separate age groups might possibly have provided different findings. Previous studies have reported 
inconsistent findings on age differences among children regarding BII fear/phobia and dental 
fear/phobia. Several studies have reported that dental fear is less common in older individuals (16, 34), 
but, like our study, these associations were not very strong. This may to some extent be due to 
developmental changes and maturation of cognitive abilities in children, and may therefore differ due 
to the age range from which the study samples are taken. These changes may perhaps not be linear 
over time (39). One should also take into account that differences in health care systems may influence 
the inconsistent age effect in studies across different countries. A less or differently 
developed/accessible dental health care system, or not affordable to certain segments of the 
population, may influence dental habits. In the study by MAJSTOROVIC et al. (17) the authors assumed 
that children who were extremely anxious at age 11 years might develop into "hardcore needle 
phobics" later on, which highlights the importance of early detection of high intra-oral injection fear. 
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By providing this particular group of children with extra attention and proper treatment, the 
development of intra-oral injection phobia may be preventable.   
  Both the strong overlap between the IOIF-s and CFSS-DS, and the fact that the pupils with 
high fear of intra-oral injections had higher mean scores on the CFSS-DS scale, indicated a 
relationship between dental fear and intra-oral injection fear within this age group. This is in 
concordance with previous findings in other age groups (11,13, 40). Even though this cross-sectional 
survey cannot determine causality, it may be hypothesized that a child who avoids intra-oral injections 
will be at risk of being exposed to more painful dental treatment, and consequently more prone to 
developing high dental fear (21, 41).   
 The higher intra-oral injection fear level among those with no prior experience with intra-oral 
injections than in those who previously had received injections at the dentist, may reflect the fact that 
the first group probably also includes avoiders. By comparing the “Avoiders” and those labelled 
“Non-avoiders”, significantly higher sum scores on all four scales (CFSS-DS, IOIF-s, MQ-c and IS-c) 
among the "Avoiders" were documented. The effect sizes though, indicating the magnitude of the 
associations, were large for the IOIF-s, CFSS-DS and IS-s, but considered very small for the MQ-c. 
This could also be  an indication of an association with dental fear, and may be seen as support for the 
division of BII-fear in the distinct subtype blood-injury and subtype injection, as described by OST (2).  
  In this sample, 10.6% of participants were characterized as "Avoiders", a figure higher than 
previously reported in Hordaland County among 18-year-olds (3.3%) (11). Nevertheless, self-reports 
on dental avoidance behavior should be interpreted with caution. The youngest children are often 
attending dental appointments in the presence of their parents or guardians. This may influence the 
child's behavior, and attendance and treatment may not be perceived as entirely optional, possibly 
influencing their response to this particular question. Hence, the wording of the "avoidance" variable 
was targeting the treatment situation involving the intra-oral injection, in which the child is more in 
position to avoid, rather than by targeting attendance to the treatment session. However, even though 
this is probably one of the closest approaches as to assess self-reported avoidance behaviour in young 
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children, this indirect approximation introduces some biases, such as possibly including some children 
afraid of other dental procedures (e.g drilling). Another factor with possible impact is the fact that the 
pupils were sitting in a classroom while completing the questionnaire, and were not exposed to the 
syringe or an actual dental situation. Since in vivo exposure to the specific anxiety provoking stimulus 
is known to generate an immediate and extreme anxiety response (1), true avoidance behavior is hard 
to predict accurately by self-reports.  
 In general, avoidance is strongly associated with specific phobias and also is one of the criteria 
for a specific phobia diagnosis (1). One may speculate that the proportion of "Avoiders" may be seen 
as an indication of the prevalence of intra-oral injection phobia in children. This estimate is somewhat 
in line with the previous study on prevalence in 10-11-year-olds, by MAJSTOROVIC et al. (17). The 
bivariate analysis revealed significant associations related to avoidance with all the variables, even 
though the sex and age factors were not as strongly related. In the multivariate analysis, the significant 
factors in the model for being predictors of avoidance were fear of intra-oral injections, dental fear and 
previous experience with intra-oral injections (Table 6). A limitation of the model was the correlation 
coefficient of 0.83 found when assessing multicollinearity between intra-oral injection fear and dental 
fear. Both variables were considered important to the analysis, and the correlation coefficient regarded 
not too strong for them to be included in the multivariate analysis. 
 A limitation of the study is that the accuracy of self-reports in children on the not validated 
variables dental attendance and avoidance may be recall biased. Additionally, they may have had 
difficulties in understanding some of the questionnaire items. Nevertheless, the pilot study revealed no 
difficulties with the wording or understanding of the questions. Also, the first author giving the 
instructions and being present at the time of completion secured standardized information on questions 
related to the content of the questionnaire during the completion. Additionally, the children, especially 
the fearful ones, might have completed the questionnaire according to what they believe to be 
'preferable', introducing a degree of social desirability bias.  This may have caused children to over-
report dental attendance and under-report avoidance and fearfulness. In an attempt to limit this effect, 
anonymity of the study was outlined, both in a written form prior to the study, and was repeated at the 
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day of completion. Another limitation is the fact that some parents/guardians (e.g immigrant parents) 
may have trouble reading Norwegian and thereby did not understand the content of the information 
sheet, yielding possible false positive consent to participation in the study. Norwegian is the language 
in which official written information from the schools is given. Parents/guardians not fluent in 
Norwegian are generally expected to seek external assistance. Additionally, even though the CFSS-DS 
had been validated only up to the age of 15, we chose to use this scale also in 16-year-olds, enabling 
comparisons across age groups. This should represent only minor problems in terms of cognitive 
development, and, additionally, the CFSS-DS is derived from a validated adult version.  
 This study has documented that high fear of BII and the subtype fear of intra-oral injections 
were prevalent among 10-16-year-olds. The strong overlap between high fear of intra-oral injection 
and high dental fear may also indicate an association between the diagnosis BII phobia and dental 
phobia according to the DSM-V criteria. High fear of intra-oral injections was also found to be 
associated with avoidance of necessary dental treatment when local anesthesia is needed. For this 
reason, intra-oral injection fear should be addressed before treatment of dental fear.   
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IOIF-s* 27.5 (11.8) 19.7 (9.1) 23.7 (11.2) 1406 F (1, 1344.5)=193.8; p<0.001) 
CFSS-DS** 28.3 (10.3) 22.3 (8.1) 25.4 (9.8) 1416 F (1, 1366)   =150.2; p<0.001) 
MQ-c 17.3 (11.1) 10.2 (9.8) 13.8 (11.1) 1417 F (1, 1406.2)=159.2; p<0.001) 
IS-c 18.4 (15.9) 9.7 (12.0) 14.1 (14.8) 1406 F (1, 1329.3)=133.1; p<0.001) 
*Cut-off score IOIF-s > 38 
**Cut-off score CFSS-DS > 38 
***SD, standard deviation 
 
Table 2 
 One-way analysis of variance evaluating the impact of sex on levels of the Intra-oral injection fear scale (IOIF-s), 
Children’s Fear Survey Schedule-Dental Subscale (CFSS-DS), Mutilation Questionnaire for children (MQ-c), and 
Injection phobia scale for children (IS-c) 
 
Table 1 
Distribution of 10-16- year-old pupils attending public elementary schools, according to age and sex 
Age Girls, n (%) Boys, n (%) Total, N (%) 
10 89   (6.2) 84   (5.9) 173   (12.1) 
11 170 (11.9) 147 (10.3) 317   (22.2) 
12 112 (7.8) 134 (9.4) 246   (17.2) 
13 107 (7.5) 92   (6.4) 199   (13.9) 
14 85   (6.0) 75   (5.3) 160   (11.2) 
15 88   (6.2) 72   (5.0) 160   (11.2) 
16 76   (5.3) 97   (6.8) 173   (12.1) 







    IOIF-high* 
  Mean (SD**)    n 
 IOIF-low* 
 Mean (SD**)   n 
Statistics 
     
CFSS-DS*** Girls 41.5 (10.4)     150 24.9 (6.9)     565 F (1, 185.0) = 343.1; p<0.001, eta sq:0.43 
 Boys 39.1 (12.8)       43 21.2 (6.4)     639 F (1, 43.4) = 82.1; p<0.001,     eta sq:0.28 
 Total 41.0 (11.0)     194 23.0 (6.9)   1215 F (1, 218.0 )= 493.3; p<0.001, eta sq:0.40 
     
MQ-c Girls 25.4 (11.7)     151 15.2 (9.9)     567 F (1, 210.5) = 96.9; p<0.001,   eta sq:0.14 
 Boys 21.7 (14.4)      44 9.4 (8.7)     636 F (1, 45.2) = 31.1; p<0.001,     eta sq:0.10 
 Total 24.7 (12.6)     196 12.1 (9.7)   1214 F (1, 234.1) = 179.7; p<0.001, eta sq:0.16 
      
IS-c Girls 38.2 (15.0)     152 13.0 (11.3)   562 F (1, 200.3) = 371.8; p<0.001, eta sq:0.42 
 Boys 36.3 (15.7)       44 7.9 (9.3)     637 F (1, 45.1) = 140.0; p<0.001,   eta sq:0.34 
 Total 37.8 (15.1)     197 10.3 (10.6)  1210 F (1, 228.6) = 604.9; p<0.001, eta sq:0.42 
 
Table 3 
One-way anaysis of variance evaluating the impact of respectively high and low scores on the Intra-Oral Injection Fear 
(IOIF) scale, of the Children’s Fear Survey Schedule-Dental Subscale (CFSS-DS), the Mutilation Questionnaire for children 
(MQ-c), and the Injection phobia scale for children (IS-c).  
 
* IOIF-high; sum score IOIF-s > 38, IOIF-low; sum score IOIF-s ≤ 38 
**SD, standard deviation 








Table 4  
One-way analysis of variance evaluating the impact of dental Avoiders* and Non-avoiders* on the Intra-oral injection 
fear scale (IOIF-s), Children's Fear Survey Schedule-Dental Subscale (CFSS-DS), Mutilation Questionnaire for children 
(MQ-c) and Injection phobia scale for children (IS-c). 
 Avoiders* 
Mean (SD**)  n 
Non-avoiders* 
Mean (SD**)    n 
Statistics 
IOIF-s  37.6 (11.6)     149 21.9 (9.8)        1255 F(1, 174.0)=249.6; p<0.001   eta sq=0.188 
CFSS-DS 36.8 (12.5)     149 24.0 (8.4)        1262 F(1, 164.3)=150.8; p<0.001   eta sq=0.164 
MQ-c 21.0 (12.9)     150 13.0 (10.5)      1262 F(1, 173.5)=53.6; p<0.001     eta sq=0.05 
IS-c 29.8 (17.7)     148 12.1 (13.1)      1256 F(1, 166.6)=139.2; p<0.001   eta sq=0.137 
*Avoiders were defined as those responding “certainly not” or "probably not", whereas Non-avoiders were those responding  
"Definitely" or "Probably" when asked if they were able to cope with dental treatment knowing that an intra-oral injection was required. 






Variable n B Odds ratio 95% CI** p 
IOIF-s*** 
   IF (score 1) 













   DF (score 1) 

















   Girls (score 1) 











  0.033 
Age‡ 
   Old (score 1) 











  0.002 
Experience with 
io-i§ 
   Yes (score 1) 


















* Avoiders were defined as those responding “certainly not” or "probably not", when asked if they were able to cope with 
dental treatment knowing that an intra-oral injection was required. 
** CI: Confidence Interval 
*** IOIF-s, Intra-oral injection fear scale; IF, high intra-oral injection fear (IOIF-s> 38) 
† CFSS-DS, Children’s Fear survey Schedule-Dental Subscale; DF, dental fear (CFSS-DS> 38) 
‡ Old, (13-16 year); Young, (10-12 year) 
§ Experience with io-i, experience with intra-oral injections 
Table 5  




-2LL: 714, 89.8% correctly predicted; Nagelkerke's R2=0.289 
 
* Avoiders were defined as those responding “certainly not” or "probably not", when asked if they were able to cope with 
dental treatment knowing that an intra-oral injection was required. 
** CI: Confidence Interval 
*** IOIF-s, Intra-oral injection fear scale; IF, high intra-oral injection fear (IOIF-s> 38) 
†CFSS-DS, Children’s Fear survey Schedule-Dental Subscale; DF, dental fear (CFSS-DS> 38) 
‡ Old, (13-16 year); Young, (10-12 year) 
§Experience with io-i, experience with intra-oral injections 
 
Variable n B Odds ratio 95% CI** p 
IOIF-s*** 
   IF (score 1)            













   DF (score 1)  













   Girls (score 1) 












  0.261 
Age‡ 
   Old (score 1) 











  0.077 
Experience with 
io-i§ 
   Yes (score 1) 











   
  0.001 
 
Table 6 
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Når fikk du bedøvelse hos tannlegen sist? 
(sett et kryss) 
□ Mindre enn et år siden 
□ Mer enn 1 år siden 
□ Har aldri fått bedøvelse hos tannlegen, eller kan ikke huske å ha fått det 
 




Når fikk du vaksine eller tok blodprøve sist? 
(sett et kryss) 
□ Mindre enn et år siden 
□ Mer enn 1 år siden 
□ Har aldri fått vaksine eller blodprøve, eller kan ikke huske å ha fått det 
 




Har du en eller flere ganger besvimt i følgende situasjoner? 
(kryss av for ja eller nei) 
 
Når jeg har fått bedøvelse hos tannlegen..............................................................□ Ja □Nei 
Når jeg er blitt vaksinert eller har tatt blodprøve hos lege/helsesøster.................□ Ja □Nei 
Når jeg har sett et menneske eller et dyr som er blitt skadet................................□ Ja □Nei 
Når jeg selv er blitt skadet eller begynt å blø.......................................................□ Ja □Nei 
Antall ganger besvimt (omtrent):  __________ 
Ikke redd i det 
hele tatt 
Så redd det går an å bli 
Ikke redd i det 
hele tatt 
Så redd det går an å bli 
 
 
Dersom du skal til tannlegen og vet at du trenger bedøvelsessprøyte for å ordne en tann, 
hvor sikker er du på at du vil komme til å møte til timen? 
(sett et kryss) 
□ Helt sikker på at jeg møter 
□ Sannsynligvis møter jeg 
□ Sannsynligvis møter jeg ikke 
□ Helt sikker på at jeg ikke møter 
 
 
Dersom du skal til tannlege og vet at du trenger bedøvelsessprøyte for å ordne en tann, 
hvor sikker er du på at du vil komme til å mestre behandlingen? 
(sett et kryss) 
□ Helt sikker på at jeg mestrer behandling 
□ Sannsynligvis mestrer jeg behandling 
□ Sannsynligvis mestrer jeg ikke behandling 











Dersom du har tatt bedøvelse, hvor smertefull var den siste bedøvelsen hos tannlegen? 
  
Ikke ubehagelig i 
det hele tatt 
Det mest ubehagelige 
jeg kan forestille meg 
Ikke smertefull i 
det hele tatt 
Det mest smertefulle jeg 
kan forestille meg 
IOIF-s * 
 




Tenk deg at du er i situasjoner som beskrevet nedenfor. Marker med å sette et kryss i ruten for 
det svaret som passer best for deg. Sett bare et kryss for hvert punkt. 
 
Hvor redd er du... 
 
 
1.   når tannlegen sier at du trenger en bedøvelsessprøyte....□.......□.........□........□..........□ 
 
 








4.   for selve bedøvelsesvæsken (bedøvelsesmiddelet).........□........□........□.........□.........□ 
 
 
















9.   når du kjenner at du blir nummen (bedøvet)..................□..........□........□........□.........□ 
 
 
10. for at bedøvelsen ikke skal virke....................................□..........□........□........□........□ 
 
 
11. når du ser nålen på en bedøvelsessprøyte.......................□..........□........□........□........□ 
 
 

















* The abbreviated heading was not present in the original questionnaire 
 
Marker med å sette kryss i ruten for det svaret som passer best. Sett bare et kryss for hvert 
punkt. 
 
Hvor redd er du... 
 
 
1.   for tannlegen..................................................................□.......□........□........□........□ 
2.   for doktoren...................................................................□.......□........□........□........□ 
3.   for å få sprøyte eller bedøvelse......................................□.......□........□........□........□ 
4.   når noen undersøker munnen og tennene dine...............□.......□........□........□........□ 
5.   når du gaper hos tannlegen.............................................□......□........□........□........□ 
6.   når noen du ikke kjenner berører deg............................□.......□........□.........□.......□ 
7.   når noen du ikke kjenner ser på deg..............................□........□........□.........□.......□ 
8.   når tannlegen borer i tennene dine.................................□........□........□........□.......□ 
9.   når du ser tannlegen bore i tennene hos en annen..........□........□........□........□.......□ 
10. når du hører tannlegeboret.............................................□........□........□........□.......□ 
11. når noen holder et instrument inni munnen din.............□........□........□........□.......□ 
12. for å kveles eller sette noe i halsen................................□........□........□........□.......□ 
13. for å måtte innlegges på sykehus...................................□.........□........□........□......□ 
14. for personer med hvite lege- eller tannlegeklær............□.........□.........□.......□......□ 
15. når tannlege eller tannpleier pusser tennene dine..........□.........□.........□.......□......□ 
Ikke redd 













* The abbreviated heading was not present in the original questionnaire 
 
Her beskrives ulike situasjoner som personer som er redde for sprøyter kan synes er 
ubehagelige. Kryss av for hvor redd du hadde vært om du befant deg i situasjonen. Husk 
på at det ikke finnes noe rett eller galt svar. 
Hvor redd er du... 
 
 
1.   Ta blodprøve ved stikk i fingeren....................................□........□........□........□........□ 
2.   Få en sprøyte i overarmen................................................□........□........□........□........□ 
3.   Se et bilde av en sprøyte..................................................□.........□........□........□........□ 
4.   Kjenne sykehuslukt.........................................................□.........□........□........□........□ 
5.   Få en bedøvelsessprøyte av tannlegen...............................□.........□.......□........□........□ 
6.   Ta en blodprøve...............................................................□........□.......□.........□.......□ 
7.   Se en person ta en blodprøve i virkeligheten.......................□.......□........□.........□.......□ 
8.   Få en sprøyte i baken........................................................□........□........□........□.......□ 
9.   Se bilde av en person som får sprøyte................................□........□........□........□.......□ 
10. Høre noen fortelle om å få sprøyte.....................................□........□........□........□.......□ 
11. Se på og ta på blodårer på armens innerside.......................□.........□........□........□.......□ 
12. Se film om en person som får en sprøyte............................□........□........□........□.......□ 
13. Se en annen person få en sprøyte i virkeligheten.................□.........□........□........□......□ 
14. Se en person i sykepleieruniform.......................................□.........□.........□.......□......□ 
15. Ta hull i ørene..................................................................□.........□.........□.......□......□ 
16. Få en vaksinasjon.............................................................□.........□........□........□......□ 
17. Få en sprøyte som går inn i en blodåre...............................□.........□.........□.......□......□ 
18. Se på at en annen person tar blodprøve ved stikk i fingeren.□.........□.........□.......□......□ 
 









* The abbreviated heading was not present in the original questionnaire 
 
 
Her beskrives ulike situasjoner som personer som er redde for blod kan synes er ubehagelige. 
Kryss av for hvor redd du hadde vært om du befant deg i situasjonen. Husk på at det ikke 
finnes noe rett eller galt svar. 
Hvor redd er du... 
 
 
1.   Se en hardt skadet person på tv.....................................□.......□........□........□........□ 
2.   Gå til sykehuset og besøke en syk eller skadet person..□.......□........□........□........□ 
3.   Se en slakter jobbe.........................................................□.......□........□........□........□ 
4.   Tenke på å jobbe som lege eller sykepleier...................□.......□........□........□........□ 
5.   Se noen som er skadet i øyet.........................................□.......□.........□........□........□ 
6.   Se en person som blør....................................................□.......□........□.........□.......□ 
7.   Se skader eller ulykker i virkeligheten...........................□.......□........□.........□.......□ 
8.   Se en operasjon på TV...................................................□........□........□........□.......□ 
9.   Hjelpe noen som er blitt skadet eller blør......................□........□........□........□.......□ 
10. Bruke skarpe kniver.......................................................□........□........□........□.......□ 
11. Tenke på å måtte opereres.............................................□.........□........□........□.......□ 
12. Å skjære meg ved et uhell..............................................□........□........□........□.......□ 
13. Se en blodflekk..............................................................□.........□........□........□......□ 
14. Se et åpent sår................................................................□.........□.........□.......□......□ 
15. Rengjøre et sår ..............................................................□.........□.........□.......□......□ 










Til foresatte til elev i        klasse 
Informasjon om spørreundersøkelse angående barn og ungdoms forhold til 
tannbehandling og bedøvelse. 
Universitetet i Bergen og Tannhelsetjenestens kompetansesenter vest-Hordaland skal 
gjennomføre et forskningsprosjekt som skal kartlegge hvordan barn og ungdom synes det er å 
gå til tannlegen, og spesielt om de er redde for blod, skader, få bedøvelse og andre 
injeksjoner. Undersøkelsen er et ledd i vårt arbeid med å kunne forebygge at barn og voksne 
får problemer med å mestre tannbehandling.  
Som del av dette prosjektet planlegges det en spørreskjemaundersøkelse blant elevene i ….. 
klasse ved …… skole. 
 
Spørreskjemaene består av følgende deler: 
 1. Generell del: Fødselsår, kjønn, erfaringer med sprøyte, blod og skader 
 2. Skjema som måler redsel for tannbehandling 
 3. Skjema som måler redsel for injeksjoner/sprøyter/vaksinasjoner 
 4. Skjema som måler redsel for bedøvelse hos tannlege 
 
Spørreskjemaene vil bli utdelt i klasserommet og skal fylles ut der. Karin G. Berge, stipendiat 
ved UiB/TkV-H, vil først veilede elevene om fremgangsmåten. Berge vil også være tilstede 
under utfyllingen. Det er avsatt ca. 1 skoletime til dette. 
 
Undersøkelsen er fullstendig anonym ved at det ikke skal skrives hverken navn eller 
klasse på skjemaet. Deltagelse er frivillig for den enkelte elev.  Dersom du/dere ikke 
ønsker at deres barn skal delta, ber vi om at svarslippen nedenfor fylles ut og tas med 
tilbake til skolen, eller at det sendes en e-post til klassens kontaktlærer eller 




Dersom det ønskes flere opplysninger om prosjektet, eller det ønskes hjelp i forbindelse med 
at barnet har problemer med tannbehandling eller bedøvelse kan dere kontakte undertegnede 









Klipp og returner…………………………………………………………………………………… 
 
Jeg ønsker ikke  at mitt barn …………………………………i klasse………skal delta i 

















Vi ber om tillatelse til å gjennomføre en spørreundersøkelse om 10-16 åringers forhold til tannlegebe-
handling, og da spesielt erfaringer forbundet med det å få satt sprøyter. I alt 1400 barn og unge er 
trukket ut på en slik måte at de representerer 10-16 åringer i Hordaland. Det er derfor av stor betyd-
ning at de uttrukne skolene sier seg villig til deltagelse. Elever i .. klasse ved …..skole er blant dem 
som er plukket ut for deltagelse. 
 
Undersøkelsen gjennomføres i løpet av 2014/2015. Deltakerne i studien og deres foresatte blir infor-
mert om at deltakelse er frivillig, og at opplysningene er anonymisert. Foresatte må samtykke til at 
deres barn kan delta i undersøkelsen.   
 
Helsedirektoratet finansierer undersøkelsen, som gjennomføres i regi av Senter for odontofobi, 
Tannhelsetjenestens kompetansesenter Vest – Hordaland og Universitetet i Bergen. Prosjektet 
er godkjent av Regional komité for medisinsk forskningsetikk. Det aktuelle spørreskjemaet er blitt 
prøvd ut på en skole i Bergen med positive tilbakemeldinger. 
 
Undersøkelsen vil bidra til økt innsikt i ungdommers forhold til sprøyter. Slik kunnskap er viktig for å 
kunne forebygge at barn og unge utvikler problemer i forbindelse med det å få satt sprøyter, og for å 
kunne gi dem som har slike problemer best mulig behandling. 
 
Elevene skal fylle ut spørreskjemaet i klasseromssituasjonen, og hver klasse som skal delta må påreg-
ne at det går med én skoletime. Stipendiat Karin G. Berge vil foreta den praktiske gjennomføringen. 
Hun vil i løpet av de neste ukene ta direkte kontakt med skolen, slik at nærmere avtale kan gjøres. 
 










Marit Slåttelid Skeie                    Margrethe Elin Vika                    Maren Lillehaug Agdal                         
Førsteamanuensis                         Psykolog, PhD                                   Tannlege, PhD 
 
U N I V E R S I T E T E T  I  B E R G E N  








Til skolesjefer i grunnskolen i Hordaland 
 




Forespørsel om tillatelse til å gjennomføre spørreundersøkelse i grunnskolen.  
 
 
Vi ønsker med denne henvendelsen å be om tillatelse til å kontakte ulike grunnskoler i utvalgte 
kommuner for å gjennomføre en spørreundersøkelse. Denne spørreundersøkelsen omhandler barn og 
unges forhold til tannlegebehandling, og spesielt da erfaringer forbundet med det å få 
bedøvelsessprøyte. Vi ser på undersøkelsen som viktig, både for å forebygge at barn og unge utvikler 
problemer i forbindelse med injeksjoner, men også for å kunne gi de som allerede har problemer med 
dette, den best mulige behandling.  
 
Spørreskjemaene som skal benyttes, har tidligere vært brukt på 154 elever i Bergen kommune med 
positive tilbakemeldinger. Denne gangen håper vi på å nå i alt 1400 elever i grunnskolen i Hordaland 
fylke i alderen 10-16 år. Elevene trekkes ut skolevis på en slik måte at de vil representere 
aldersgruppen i fylket. Planen er at elevene fyller ut spørreskjemaet i et klasserom. Hver klasse som er 
trukket ut til å delta, må regne med at det går med ca én skoletime. Den praktiske gjennomføringen vil 
foretas av stipendiat Karin Berge.  
 
Helsedirektoratet finansierer undersøkelsen, som gjennomføres i regi av Senter for odontofobi, 
Tannhelsetjenestens kompetansesenter Vest - Hordaland og Universitetet i Bergen. Prosjektet er 
godkjent av Regional komité for medisinsk forskningsetikk. Det innebærer at deltakerne i studien 
blir informert om at deltakelse er frivillig, og at opplysningene blir anonymisert. Alle foresatte av 
berørte elever mottar informasjonsskriv og må samtykke til at deres barn kan delta i undersøkelsen. 
 
Dersom du har spørsmål som du ønsker svar på, kan du sende e-post til stipendiat Karin Goplerud 
Berge (karin.berge@hfk.no), ringe Senter for odontofobi 55 58 64 62/55 58 37 93, eller ta kontakt 














Marit Slåttelid Skeie               Margrethe Elin Vika   Maren Gry Lillehaug Agdal  








Forespørsel om deltagelse i forskningsprosjektet 




Bakgrunn og hensikt 




om tillatelse til at barnet deltar i en behandlingsstudie for å undersøke effekten av en 
behandling for å mestre bedøvelse (sprøyte) hos tannlege. 
 
Hva innebærer studien? 
Formålet med studien er å undersøke effekten av en behandlingsmetode for barn med angst 
for bedøvelse hos tannlegen. Metoden er kunnskapsbasert, og er den anbefalte 
behandlingsmetoden nasjonalt i forhold til en slik angst. 
   
Prosedyre: 
1.time: Barnet vil først bli bedt om å fylle ut noen spørreskjema. Deretter får barnet en 
samtale med psykolog for å diagnostisere barnets angstproblemer, samt en test for å 
undersøke hvorvidt det mestrer sprøyten eller ikke. Etter dette avtales med barn og foresatte 
om man ønsker deltagelse i studien eller ikke.  
Dersom barnet inkluderes i studien, blir det enten tilbudt time til behandling den påfølgende 
uken, eller hun/han blir satt på venteliste i 5 uker og deretter tilbudt behandling. 
 
Postadresse: Årstadveien 19, 5009 Bergen – Telefon: 55 58 64 62 / 55 58 53 21 – E-post: karin.berge@hfk.no 
 
2.-6. time: Behandlingen gjennomføres av tannlege over inntil 5 seanser der de viktigste 
prinsippene er følgende: informasjon, kontroll, gradvis eksponering og samarbeid. Barnet 
bestemmer selv tempoet og kan når som helst avbryte.  Når barnet mestrer sprøyten avsluttes 
behandlingen. 
 
Video:  Det vil bli tatt video av alle behandlingssekvensene for å kvalitetssikre behandlingen. 
Opptakene oppbevares nedlåst, og kun medlemmer av forskergruppen vil få adgang til å se 
dem. Når barnets kontakt med senteret avsluttes, vil de bli slettet. De vil ikke bli brukt i 
undervisningssammenheng med mindre dere er blitt forespurt og har gitt skriftlig tillatelse til 
dette på forhånd. 
 
Oppfølging 1 uke etter: Barnet får time ca. en uke etter behandlingen avsluttes for å evaluere 
resultatet av behandlingen. Det innebærer ny utfylling av spørreskjema og en test på om 
barnet mestrer tannlegesprøyte. Deretter vil hun/han bli henvist tilbake til sin vanlige 
tannlege. 
Oppfølging 1 år etter: Barnet vil bli innkalt for ny evaluering av resultatet av behandlingen. 
Dette innebærer utfylling av spørreskjema, intervju med psykolog og test om barnet mestrer 
tannlegesprøyte.       
 
Mulige fordeler og ulemper 
Mange typer tannbehandling er smertefull uten bedøvelse, og den mulige gevinsten for barnet 
er å bli kvitt en type angst som hindrer nødvendig behandling, både nå og i fremtiden. 
Deltagelse i studien krever en ekstra oppfølgingsseanse etter endt behandling, og en 
kontrollseanse ett år etter ferdig behandling. Halvparten av deltagerne i studien vil også, etter 
loddtrekning, stå på venteliste i 5 uker før behandling.  Utover dette er behandlingen 
tilnærmet lik ordinær behandling ved Senter for odontofobi.  
 
Hva skjer med informasjonen om barnet? 
Spørreskjema og notater gjort av psykolog og tannlege lagres i Senter for odontofobi i hht. 
Forskrift om journalføring. Forskningsdata skal lagres i en datafil på Universitetet i Bergen 
uten navn og fødselsnummer eller andre direkte gjenkjennende opplysninger. En kode knytter 
barnet til denne datafilen gjennom en navneliste som oppbevares atskilt fra datafilen.  
Postadresse: Årstadveien 19, 5009 Bergen – Telefon: 55 58 64 62 / 55 58 53 21 – E-post: karin.berge@hfk.no 
 
Det er kun autorisert personell knyttet til prosjektet som har adgang til navnelisten og som kan 




Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi noen grunn trekke 
ditt samtykke til at barnet deltar i studien. Dette vil ikke få konsekvenser for barnets 
tilbud om gratis behandling hos Senter for odontofobi og i Den offentlige 
tannhelsetjenesten.  
 
Rett til innsyn og sletting av opplysninger om barnet 
Hvis du sier ja til at barnet deltar i studien, har du rett til å få innsyn i hvilke opplysninger som 
er registrert om barnet. Du har videre rett til å få korrigert eventuelle feil i de opplysningene 
vi har registrert. Dersom du trekker barnet fra studien, kan du kreve å få slettet innsamlede 
opplysninger, med mindre opplysningene allerede er inngått i analyser eller brukt i 
vitenskapelige publikasjoner. 
 
Økonomi og forskning  
Behandlingen er gratis, men reiseutgiftene dekkes ikke av prosjektet. Barnet er forsikret etter 
vanlige regler for pasienter som behandles i Den offentlige tannhelsetjenesten og i 
Odontologisk klinikk på Universitetet i Bergen.  
 
Dersom du ønsker at barnet skal delta, undertegner du samtykkeerklæringen på neste side. 
Dersom du har spørsmål til studien, kan følgende kontaktes: 
  
Karin G. Berge                                                                                       
Tannlege, stipendiat 
Tlf: 55 58 53 21 
 
Marit Slåttelid Skeie                Margrethe Elin Vika                        Maren Lillehaug Agdal 
Førsteamanuensis                      Psykolog, PhD                                    Tannlege, PhD     
     




Samtykke til deltakelse i studien 
«Behandling av angst for bedøvelse hos tannlegen» 
 
              
         ..………………… 
                 Sted, dato 
 




deltar i studien slik den er beskrevet i informasjonen. Jeg/vi samtykker også til at det blir tatt 
video av alle behandlingssekvensene, men da under den forutsetning at opptakene oppbevares 
nedlåst og at kun medlemmer av forskergruppen har adgang til opptakene. Opptakene kan 
ikke brukes i undervisningssammenheng uten at jeg/vi er blitt forespurt og gitt skriftlig 
tillatelse på forhånd.  
 
………………………………………………………………………….. 
Foresattes underskrift (en eller flere) 
 
 
……………………………………………. 
Barnets underskrift 
